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Introduction: Moringa oleifera (MO) is a highly nutritional medicinal plant mainly located in 
Africa and Asia. It is traditionally used to treat a diverse array of illnesses. Hepatocellular 
carcinoma (HCC) is one of the most common cancers worldwide and the second leading cause of 
cancer related deaths. This study investigated the antiproliferative and cytotoxic effect of Moringa 
oleifera crude aqueous leaf extract (MOE) in the HepG2 cell line. 
Materials and Methods:  HepG2 cells were treated with a range of MOE concentrations (0-4 000 
µg/ml) over 72 h. An IC50 was obtained from the MTT assay and used in all subsequent assays. 
The cells were then assayed for oxidative stress and membrane damage (TBARS and LDH 
cytotoxicity), apoptotic induction (ATP levels, 3/7 activities), cytochrome P450 3A4 activity 
(Luminometry), DNA and nuclear fragmentation (Comet and Hoechst assay). Additionally, 
cytokine production of IL-6 was quantified (ELISA) and relative protein expression of NF-kB, 
phospho-STAT3 and cleaved PARP-1 was evaluated (Western Blotting). 
Results: MOE caused a dose-dependent decrease in cell viability (IC50 of 754.0 µg/ml), a 
significant increase in ROS-induced lipid peroxidation (1.23-fold, p < 0.05), extracellular LDH 
levels (1.17-fold, p < 0.0035) and significant decrease in intracellular ATP levels (1.46-fold, p < 
0.0441). DNA integrity was compromised as indicated by increased DNA fragmentation (p < 
0.0001).  MOE increased protein expression of NF-kB (1.31-fold, p < 0.0112) and p-STAT3 
(2.78-fold, p < 0.0277) whilst increasing cytokine production of IL-6 (1.20-fold, p < 0.0292). 
MOE induced apoptosis by significantly increasing caspase 3/7 activity (2.83-fold, p < 0.0469). 
Furthermore, MOE induced PARP-1 cleavage (1.11-fold, p < 0.0354) and apoptotic body 
formation in HepG2 cells. 
Conclusion: MOE does not act via the inflammatory pathway in HepG2 cells however it exerts its 
antiproliferative, cytotoxic and genotoxic effects in human HepG2 cancer cells by affecting 






Moringa oleifera (MO) is an edible plant, native to Northern Indian subcontinents but is now 
commonly distributed throughout Asia and Africa (Ramachandran et al., 1980; Anwar et al., 
2007; Mbikay, 2012;). It is a highly nutritious plant consumed in many countries and is also 
utilised in traditional medicine but in western societies, MO remains a relatively novel food 
substance (Anwar et al., 2007; Shanker et al., 2007).  
Almost every part of the MO plant from the leaves to the fruit, bark and seeds can be used to treat 
a diverse array of ailments.  The leaves are the most widely cultivated part of MO due to its 
phytochemical composition and their associated medicinal properties. MO leaves are a rich source 
of kaempferol, quercetin, alkaloids, gallic acid, tannins, saponins, vitamins and minerals (Ferreira 
et al., 2008; Kasolo et al., 2010; Leone et al., 2015), all of which contribute to the anticancer, 
antiproliferative, antioxidant and anti-inflammatory properties of MO. In previous studies MO 
aqueous crude leaf extracts has expressed anticancer effects in both A549 lung cancer cells and 
SNO oesophageal cancer cells (Tiloke et al., 2013, 2016)  as well as KB tumour cells  (Sreelatha 
et al., 2011) in a ROS-dependent manner.  
Inflammation is an important physiological process required to protect against infection and 
restore injuries sustained by tissues. Nevertheless, chronic inflammation can trigger a variety of 
inflammatory-associated diseases. One such disease is hepatocellular carcinoma (HCC), which is 
the fifth most frequent neoplasm worldwide and the second leading cause of cancer-related 
mortality. Primary liver malignancies account for approximately 7% of all cancers  and HCC 
signifies more than 90% of all primary cancers (Yan et al., 2015). Chronic hepatitis B virus (HBV) 
infection and prolonged exposure to dietary fungal toxin, aflatoxin B1 (AFB1) are prominent 
factors influencing the development of HCC amongst  sub-Saharan black Africans (Kew, 2010). 
Other factors contributing to HCC development includes alcohol consumption, westernised diets 
and genetic predispositions (Sherlock and Dooley, 2008). Despite the development of new 
treatment modalities, HCC still remains an escalating burden in many developing countries such 
as South Africa and is becoming widespread throughout wealthy westernised nations (Fan et al., 
2014).  
This study investigated the antiproliferative and cytotoxic effects of Moringa oleifera crude 
aqueous leaf extract and its effect on inflammation in the HepG2 cell line after 72 hour (h) chronic 
exposure. 
 
1.2 Aims and Objectives 
The null hypothesis of this study is stated that MOE does not have an antiproliferative and 
cytotoxic effect on HepG2 cells following a chronic exposure (72 h). 
The aim:  
To determine the antiproliferative and cytotoxic effects of MOE on human hepatocellular 
carcinoma (HepG2) cells by investigating the biochemical molecular mechanisms contributing to 
cell death following chronic exposure.  
The objectives of the study were to investigate the effects of MOE on:  
 Cell viability and metabolic activity in HepG2 cells using the MTT assay.  
 Cytochrome P450 activity and drug metabolism using luminometric quantification. 
 The magnitude of ROS-induced lipid peroxidation and RNS in HepG2 cells exposed to 
MOE by quantification of the biomarker, malondialdehyde (MDA) using the TBARS 
assay and the Nitrates and nitrites assay. 
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 Cell membrane integrity using the lactate dehydrogenase (LDH) cytotoxicity detection 
assay to determine the presence of extracellular LDH and intracellular luminometric 
quantification of adenosine triphosphate (ATP). 
 The regulation, induction or inhibition of inflammatory mediators using western blotting 
to determine protein expression of transcription factors (NF-kB  and STAT3) and ELISA 
to quantify cytokine production (IL-6, TNF-, IL-10 and IL-1β). 
 The apoptotic pathways induced using luminometric quantification of intracellular 
caspase (8, 9 and 3/7) activities. 
 DNA integrity by assessing DNA fragmentation via the comet (SCGE) assay and DNA 
repair enzyme PARP-1 protein expression using western blotting. 
 Cellular and nuclear morphological features using Hoechst nucleic stain assay.  
 
Experimental approach: 
The human hepatocellular carcinoma HepG2 cell line was used as cell toxicity model to 
investigate the antiproliferative and cytotoxic effects of MOE against liver cancer. Cells were 
treated over a 72 h period with a range of concentrations to determine cell viability. This resulted 
in a concentration-dependent decrease in viability and the concentration which was half the 
maximum inhibition (IC50) was deduced. This concentration was used to test the mechanisms 




1.3 Literature Review 
1.3.1 Moringa oleifera  
1.3.1.1 Botanical characterisation 
The monogeneric Moringaceae plant family consists of a single Genus and 13 species (Dangi et 
al., 2002; Leone et al., 2015). Moringa oleifera (MO) is the most well-known and extensively 
studied member of the family (Ramachandran et al., 1980; Sakpere, 2016) and is commonly 
referred to as the “Drumstick”, “Horse radish” or “Ben oil” tree (Fahey, 2005; Spandana and 
Srikanth, 2016). This medium-sized, deciduous tree is rapid growing, often reaching heights 
between 10 to 12 metres. The thick, softwood bark appears whitish grey, branches are brittle and 
wide spread, surrounded by feathery greenery of tripinate leaves. It also bares bisexual yellow-
white flowers in lateral clusters and pensile linear fruits (Figure 1.1) (Parrotta, 1993; Amabye and 
Tadesse, 2016).  
 
Figure 1.1: A. Moringa oleifera tree, B. Mature bark, C. Flower cluster, D. Leaves  and E. 
Fruit  [Adapted from (Roloff et al., 2009; Leone et al., 2015)]. 
 
1.3.1.2 Distribution 
Classified as a perennial tree, MO has a life span greater than two years and favourably grows in 
tropical and subtropical geographical locations that experience dry to moist climate conditions 
(Leone et al., 2015). The MO tree is indigenous to the sub-Himalayan areas of India, Afghanistan, 
Bangladesh and Pakistan.  Once utilised by ancient Egyptians, Greeks and Romans, it has now 
become naturalised in many tropical locations and is an important crop cultivated throughout 
North and South America, Asia and Africa (Ramachandran et al., 1980; Anwar et al., 2007; 
Mbikay, 2012). 
 
1.3.1.3 Traditional uses 
The entire MO plant can be implemented in non-medicinal practises. The honey collected from 
the nectar of the flowers can be consumed, seeds are crushed and used as coagulants for water 
treatment and the oils are extracted and used as machine lubrication or in the production of 
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cosmetic products. The leaves are commonly crushed and used as organic domestic cleaning 
agents or as gaseous fuels (Fahey, 2005; Pereira et al., 2016). Worldwide, MO has mainly been 
associated with traditional medicine, with the leaves being utilised the most. MO leaves have high 
nutritional status and are therefore used as a nutritional supplement  incorporated within food  in 
developing countries plagued by malnutrition (Kasolo et al., 2010).  They can also be used to treat 
fever, malaria, skin diseases (Stevens et al., 2013), wounds (Rathi et al., 2006), diarrhoea 
(Lakshminarayana et al., 2011), indigestion and eye  infections (Muthu et al., 2006). 
 
1.3.1.4 Phytochemistry 
Several bioactive phytochemical compounds have been positively identified in MO leaves 
including vitamins, flavonoids, alkaloids, tannins, saponins, oxalates and phytates (Kasolo et al., 
2010; Leone et al., 2015). 
Fresh MO leaves are a rich source of  vitamin A, B, C and E. Vitamin A (βeta-carotene) has major 
roles in several physiological processes such as cell proliferation, differentiation, apoptosis, 
embryonic growth and development, vision, immune proficiency and brain function (Kidmose et 
al., 2006). In developing countries, vitamin A deficiency is a common occurrence and may be 
responsible for mortality amongst women and children (Álvarez et al., 2013). Among group B 
vitamins, only biotin, niacin, riboflavin, thiamine and pyridoxine appear to be present in MO 
leaves. These vitamins principally act as enzyme cofactors involved in energy production and 
nutrient metabolism (Moyo et al., 2011; Leone et al., 2015). Vitamin C is a mediator of synthesis 
and metabolism of many compounds, like lysine, proline, glycine hydroxylation, tryptophan, folic 
acid and tyrosine. Additionally, it increases gastrointestinal iron absorption by reducing ferric to 
ferrous state and it expedites the conversion of cholesterol into bile acids to reduce blood 
cholesterol levels. Vitamin C serves as an antioxidant in a bid to protect the body from various 
destructive effects of free radicals, toxins and pollutants (Chambial et al., 2013). Vitamin E 
predominately functions as a lipid soluble antioxidant and modulates expression of genes. It also 
has an inhibitory role during cell proliferation, monocyte adhesion, platelet aggregation and bone 
mass regulation (Borel et al., 2013). An important component of vitamin E is -tocopherols, an 
antioxidant that prevents lipid peroxidation caused by the generation of free radicals. Peroxides 
damage cell membranes, tocopherols metabolise peroxides thus maintaining the redox state 
within cells. Disruption of intracellular redox state promotes oxidative stress resulting in diseases 
such as cancer and atherosclerosis. Elevated levels of tocopherols are found throughout the plant 
(Ferreira et al., 2008). 
Flavonoids are omnipresent, polyphenolic plant compounds containing a benzo-γ-pyrone 
structure and are synthesized in response to microbial infections (Kumar and Pandey, 2013).  
Epidemiological studies have shown that high flavonoid intake has protective effects against 
cancers, cardiovascular diseases and viral and bacterial infections (Pandey and Rizvi, 2009; 
Kumar and Pandey, 2013). The two main flavonoids found in MO leaves are quercetin and 
kaempferol (Leone et al., 2015). Both flavonoids contain phenolic hydroxyl groups, possess 
antioxidant activities and provide protection against damage caused by radiation, inhibition of 
prostaglandin synthesis and cell cycle progression as well as mutations and carcinogenesis 
(Ferreira et al., 2008).  
Alkaloids are a group of basic plant chemical compounds existing in nature containing oxygen, 
nitrogen, hydrogen and carbon atoms (Goss, 2012). A great interest has been generated with 
regards to alkaloids due their pharmacological activities; these plant products exert antimicrobial 
effects through intercalation with the DNA of microorganisms. The presence of alkaloids has 
been positively identified in MO leaves (Sreelatha and Padma, 2009; Kasolo et al., 2010). 
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Phenolic acids are a sub-group of naturally occurring phenol compounds derived from 
hydroxycinnamic and hydroxybenzoic acid (Prakash et al., 2007). Gallic acid and tannins are two 
important phenolic compounds present in MO leaves. Gallic acid (GA) (3,4,5-tri-hydroxybenzoic 
acid) is a natural triphenolic compound. It provides defence against reactive oxygen species 
(ROS)-induce oxidative damage and is considered to be the main contributing component 
responsible for antioxidant properties of MO ( Prakash et al., 2007; Badhani et al., 2015). Tannins, 
an important water soluble phenolic compound, bind and precipitate alkaloids and a wide variety 
of proteins. They have been shown to exhibit anti-hepatotoxic, anti-inflammatory and anti-cancer 
properties (Kancheva and Kasaikina, 2013).  
Saponins are a group of natural bioactive glycoside compounds that consist of an isoprenoidal-
derived aglycone, designated genin or sapogenin, linked covalently to one or more sugar 
molecules (Leone et al., 2015). They have anti-inflammatory, antioxidant, anticancer and 
immunostimulatory properties (Moses et al., 2014). Previous studies by Bauman et al. (2000) 
indicated saponins induced cytotoxicity in human erythrocytes by forming complexes with 
cholesterol present in the cell membrane leading to pore formation and permeabilisation of the 
cell (Baumann et al., 2000; Devisetti et al., 2016). MO leaves also possess a rather high content 
of oxalates and phytates, these compounds are anti-nutritional and inhibit minerals reabsorption 
in the intestines (Leone et al., 2015). 
 
1.3.1.5 Pharmacological activities 
Earlier studies have confirmed the pharmacological activities associated with MO such as its 
hypoglycaemic (Jaiswal et al., 2009), hypolipidemic (Mehta et al., 2003; Yadav and Srivastava, 
2016), hypotensive (Dangi et al., 2002; Stohs and Hartman, 2015), hepato and kidney protective 
abilities , all of which are mainly attributed to its leaves (Leone et al., 2015). 
A study by Coppin et al. (2013) confirmed the anti-inflammatory activity of three randomly 
selected samples of MO leaves and found that two samples actively attenuated the production of 
nitric oxide (NO) by bacterial lipopolysaccharide (LPS)-stimulated macrophage cells whilst the 
third sample was found to be non-active. The authors credited this variance to the plants chemical 
composition and genotype which can vary within the species (Coppin et al., 2013). An 
experimental study carried out by Waterman et al. (2014) utilised concentrated MO leaf derived 
isothiocyanates on macrophages and observed a significant decrease in the gene expression of 
interleukin-1 beta (IL-1β) and inducible nitric oxide synthase (iNOS). In addition, the production 
of NO and tumour necrosis factor alpha (TNF-) was also inhibited by both isolates (Waterman 
et al., 2014). Kooltheat et al. (2014) identified that the ethyl acetate extract of MO leaves 
prohibited interleukin-6 (IL-6), interleukin-8 (IL-8) and TNF- cytokine production by human 
macrophages (Kooltheat et al., 2014).  Fard et al., (2015) evaluated the anti-inflammatory effect 
of MO hydroethanolic bioactive leaves extract and showed that it significantly inhibited the 
production of NO, TNF-, IL-6, and IL-1β. The bioactive compound had induced interleukin-10 
(IL-10) production in a dose-dependent manner. Additionally, the extract had efficiently inhibited 
the expression of nuclear factor kappa-light-chain-enhancer of activated B-cells p65 (NF-kB p65), 
iNOS and cyclooxygenase 2 (COX-2) in LPS-induced RAW264.7 macrophages in a dose-
dependent manner (Fard et al., 2015). 
MO leaves also possess the capability to protect an organism against oxidative DNA damage 
associated with cancer. Numerous studies analysed the anticancer properties of ethanolic and 
water extracts of MO leaves on different types of cancer cells. The intracellular activity of MO 
leaves aqueous extract was a subject of interest in human KB tumour cell lines. Sreelantha and 
co-workers showed that MO leaves inhibit cell proliferation in a dose dependent manner 
(Sreelatha et al., 2011). The antiproliferative effect was accompanied by apoptosis induction, 
morphological cellular alterations and fragmentation of DNA. In 2013, Tiloke et al. observed a 
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significant increase in ROS concurrent with diminished intracellular glutathione levels in human 
A549 lung cancer cells treated with MOE (166.7 μg/ml ) brought about by the reduced expression 
and activation of antioxidant protein, Nrf-2. The apoptotic inducing properties of MO leaves was 
confirmed by significant increases in the activity of initiator caspase 9, effector caspase 3/7, p53 
protein and elevated Smac/DIABLO expression in MO treated cells. MO leaves extract has also 
been pin pointed in the proteolytic cleavage and subsequent activation of poly (ADP-ribose) 
polymerase 1 (PARP-1) into 24 kDa and 89 kDa fragments. Hence, MOE exerts antiproliferative 
effects in A549 lung cells through the upregulation of oxidative stress, DNA fragmentation and 
apoptosis induction (Tiloke et al., 2013). A study carried out by Jung et al. (2015) not only 
confirmed the antiproliferative and apoptotic induction of tumour cell but also revealed MO 
leaves heightened cytotoxicity on tumour cells in comparison to normal healthy cells (Jung et al., 
2015). In pancreatic cancer cells (Panc-1), MO leaves inhibited cell survival through cumulative 
cell apoptosis partially due to the down-regulation of NF-KB  key signalling proteins (Berkovich 
et al., 2013).  The ethanolic extract of MO leaves inhibited cell survival and proliferation of colon 
cancer cell lines, hepatocellular carcinoma (HepG2) , acute lymphoblastic leukaemia  and acute 
myeloid leukaemia cells (Khalafalla et al., 2010; Pamok et al., 2012). A relatively recent 
cytotoxicity study by Charoensin demonstrated the cytotoxic effect of the dichloromethane 
extract of MO against several human cancer cell lines including breast adenocarcinoma (MCF-
7), colorectal adenocarcinoma (Caco-2) and HepG2. It was also established that the 
dichoromethane extract had a greater potency than the methanolic extract but both extracts were 
deemed non-toxic when tested on human fibroblast (Charoensin, 2014). 
 
1.3.2 Liver 
1.3.2.1 Structure and function 
The liver is the largest organ of the human anatomy,  it has a functional purpose in essential 
biological processes including bile secretion, iron and vitamin storage, plasma protein synthesis 
and degradation, regulation of hormones, amino acid, lipid and xenobiotic metabolism (Baynes 
and Dominiczak, 2007; Akhter, 2013). The human liver is comprised of four lobes and several 
lobules containing bile ducts, blood sinusoids and hepatocytes.  The central hepatic vein passes 
through each lobule, surrounded by the hepatic portal vein and artery which promotes a tightly 
regulated communication between the liver and both the lymphatic and vascular system 
(Malarkey et al., 2005; Zatloukalová, 2008).   
 
1.3.2.2 Cells of the liver 
Hepatocytes are the primary cell population located within the liver, other cells include hepatic 
stellate cells, Kupffer cells and Sinusoidal endothelial cells (Malarkey et al., 2005). Hepatocytes 
are parenchymal cells representing 80% of all liver cells (Akhter, 2013). They actively partake in 
the hepatic production of bile as well as in the metabolism of vitamins, metals, lipids, glycides 
and proteins. Furthermore, these cells assist in energy storage, detoxification and excretion 
processes (Zatloukalová, 2008). Hepatic stellate cells (HSC) are storage cells for fats and vitamin 
A. In response to liver damage, HSC participate in the commencement and progression of hepatic 
fibrosis and thus may contribute toward hepatic carcinogenesis (Kmieć, 2001; Akhter, 2013). 
Kupffer cells are hepatic macrophages activated by gastrointestinal endotoxins. These cells are 
known to have high secretory, endocytic and phagocytic activities (Kmieć, 2001; Choi et al., 
2011). Sinusoidal Endothelial cells (SEC) are non-parenchymal cells and function as the 
communication mediator between the inner sinusoidal space and hepatocytes (Kmieć, 2001; 
Akhter, 2013). Endothelial cells also prevent the hepatic parenchymal infiltration of pathogens.  
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Additionally sinusoidal cells participate in the regulation of blood flow, degradation of toxic 
agents and in metabolic exchanges between the hepatocytes and plasma (Akhter, 2013). 
 
1.3.2.3 Xenobiotic metabolism 
The liver plays a pivotal role in xenobiotic metabolism. This mechanism of detoxification 
facilitates excretion of foreign chemicals from the body, however this process may lead to the 
unintentional rise in reactive metabolite production (Zatloukalová, 2008). Pollutants present in 
the environment, toxins, additives in food and drugs are just a few xenobiotics that may be 
encountered daily through absorption via the skin or inhalation, which leads to multiple organs 
being exposed to toxic xenobiotic metabolites. Xenobiotics gain access to cells by either 
specialised protein or passive transport. Once inside the cell, the xenobiotic is metabolised by 
phase I and II enzymes. Phase I enzymes include cytochrome P450 enzymes(Zatloukalová, 2008), 
which catalyses peroxidation, epoxidation, dehalogenation, deamination and hydroxylation 
reactions. Phase II enzymes also known as conjugation enzymes, catalyse the conjugation of 
phase I metabolites for the sole purpose of creating a water soluble complex which can be 
efficiently excreted from the body. Glutathione, adenosine-3´- phosphate-5´-phosphosulfate and 
uridine diphosphate (UDP)-glucuronate serve as conjugation donors (Nebert and Dalton, 2006; 
Zatloukalová, 2008). 
 
Figure 1.2: Cytochrome P450 catalysed chemical reaction (Kalra, 2007). RH, O2, nicotinamide 
adenine dinucleotide phosphate (NADP+) and R-OH represents the xenobiotic compound, 
oxidant, reducing agent and oxidised xenobiotic metabolite respectively. 
 
1.3.2.4 Cytochrome P450 
Cytochrome P450 (CYP) proteins are a superfamily of heme-containing mono-oxygenases and 
they have a well-established  role in drug discovery and development (Guengerich, 1999; Zangar 
et al., 2004). CYP enzymes are dynamically involved in regulating the synthesis and metabolism 
of eicosanoids, retinoic acid hydroxylation, bile acids, cholesterol, vitamin D3, biogenic amines 
and steroids (Nebert and Russell, 2002; Nebert and Dalton, 2006). Phase I reactions involved in 
the mechanism of detoxification are catalysed by CYP enzymes whereby they facilitate the 
addition of functional groups or modify existing functional groups located on the xenobiotics in 
order to create a more polar compound to aid phase II reactions (Westerink and Schoonen, 2007). 
In humans, the distribution of CYPs is widespread. They can be located in the vascular smooth 
muscle tissues, nasal mucosa, lungs, intestine and liver. Intestinal and hepatic CYPs play 
fundamental roles in oxidation of xenobiotics (Zanger et al., 2004; Mukherjee et al., 2011; Pillay 
et al., 2013). These enzymes also have a major role in pro-carcinogen metabolic activation and 
the subsequent activation to carcinogens that contribute to tumorigenesis or are capable of 
inducing mutations within the DNA. Thus mutations arising in CYP enzymes or dysregulation of 
CYP associated signalling pathways may contribute toward cancer development and disorders in 





The CYP3A enzyme subfamily is the most abundantly expressed CYP and comprises of three 
isoforms, CYP3A7, CYP3A5 and CYP3A4. The most  highly expressed CYP is CYP3A4 within 
the liver and small intestine where it represents 50% of the CYP total content and it  plays a 
significant role in the metabolism of xenobiotic and drugs (Guengerich, 1999; Basheer and 
Kerem, 2015). The CYP3A4 enzyme is expressed to a lesser extent in extrahepatic tissues such 
as the lung (Pillay et al., 2013). The CYP catalytic cycle involves molecular oxygen (O2) 
reduction and oxidation. The enzyme, nicotinamide adenine dinucleotide phosphate hydrogen 
(NADPH)-P450 reductase provides electrons for the oxidation of NADPH. Generally, the cycle is 
initiated by the binding of substrate (RH) to the CYP’s active heme-centre. The ferric iron (Fe3+) 
is reduced, followed by the binding of O2, reduction of O2 and cleavage of O2 at the O-O bond 
leading to the formation of water. The substrate undergoes reaction with the active perferryl FeO 
species (FeO3+) and finally the product is released, as seen in Figure 1.3 (Guengerich, 1999; Pillay 
et al., 2013). The CYP catalytic cycle produces ROS as a by-product. Electrons are leaked out 
during the cycle at various steps causing the continuous formation of ROS. Puntarulo and 
Cederbaum (1998) conducted a study investigating CYPs ability to generate ROS and found that 
CYP3A4 was the most active CYP isoform in catalysing NADPH oxidation and producing 
superoxide (O2·-) (Puntarulo and Cederbaum, 1998; Pillay et al., 2013).   
 
Figure 1.3: The catalytic cycle of cytochrome P450 3A4 (Guengerich, 1999). 
 
Drug-drug interactions that alter the activity of CYP3A4 have been extensively studied. 
Consumption of drugs in combination may lead to one drug proficiently controlling the 
metabolism of the second drug through CYP3A4 induction or inhibition. This may result in either 
toxic levels of the drug or sub-therapeutic levels. In the same way, phytochemical compounds 
found in medicinal plants may inhibit or induce CYP3A4 and are therefore vulnerable to 
alterations arising in co-administered drug metabolism  which may contribute to the risk of severe 
adverse reactions (Mukherjee et al., 2011; Pillay et al., 2013). On the other hand, CYP3A4 
induction may lead to amplified drug elimination resulting in reduced drug plasma concentrations, 
diminished efficiency and effectiveness and failure of treatment  (Mukherjee et al., 2011). 
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Another possibility that may arise is increased xenobiotic metabolism such as carcinogens. This 
may lead to the bioactivation and transformation of substances resulting in toxic and highly 
reactive metabolites being formed (Westerink and Schoonen, 2007; Pillay et al., 2013). 
 
1.3.3 Cancer  
1.3.3.1 Hepatocellular carcinoma 
Cancer is defined as “a group of diseases characterised by unregulated division and spread of 
abnormal cells” (Auyang, 2006).  Solid malignant tumours are a common occurrence and develop 
within various bodily tissues including the prostrate, breast, colon and liver. Usually malignant 
tumours can be treated or removed if it remains localised however they often tend to metastasise. 
Metastasis is a process involving the evasion of the cancer cells from the immune response, in 
doing so, the cancer cells survive and migrate away from the parent mass, gaining access to the 
blood or lymphatic circulation. They invade surrounding tissues and organs where they form 
lethal secondary tumours (Auyang, 2006).   
In spite of the liver’s detoxification and regenerative capacity, it remains the main target for toxin-
induced liver damage by xenobiotic agents. Congenital and genetic predispositions, drugs, 
hepatitis viruses, diabetes mellitus type 2, westernised diets, alcohol and chronic inflammation 
are a few main factors that facilitate the development and progression of hepatic diseases ranging 
from fibrosis and cirrhosis to acute liver failure (Sherlock and Dooley, 2008; Koh et al., 2013). 
These hepatic diseases are prominent predispositions for the development of hepatocellular 
carcinoma (HCC) (Figure 1.4). Worldwide, HCC is the most common occurring cancer and is 
mainly associated with hepatic cirrhosis and hepatitis B viral infections. Several cellular 
mechanisms and molecular pathways are evidently modified during hepatic carcinogenesis 
(Zatloukalová, 2008). Chronic viral infections such as hepatitis B virus (HBV) and continuous 
long term exposure to dietary fungal toxin, aflatoxin B1 (AFB1) are eminent factors in 
development of HCC amongst  sub-Saharan black Africans (Kew, 2010). HBV association with 
HCC development is through its various mechanism some of which include gene expression 
deregulation of important cell survival (p53), differentiation (E-cadherin) and proliferation (AP-
1, NF-κB and Wnt/β-catenin) genes. It also has the ability to activate or deactivate of retinoic acid 
β-receptor or cyclin A. additionally,  HBV prompts epigenetic modifications and causes 
instability of chromosomes which arises from the insertion or deletion of provirus or by the direct 
effects exerted by the viral HBx proteins (Zatloukalová, 2008). AFB1 exerts is tumorigenic effect 
through inactivation of cell cycle regulation, gene expression of p53 protein and by directly 
reacting with DNA molecules ultimately resulting in the formation of DNA adduct and tumour 
initiation (Zatloukalová, 2008).  Even though the pathogenesis of HCC has been extensively 
studied, the molecular mechanisms underlying the aetiology of HCC remain poorly understood, 
particularly in regard to the role and influence of xenobiotics in the initiation of hepatic 





Figure 1.4: Risk factors of HCC development (Prepared by author). 
 
1.3.3.2 In-vitro model  
The attenuation of prospective drugs during the late stages of drug development is commonly 
attributed to drug-induced hepatic injury. Accordingly, early detection of drug-induced 
hepatotoxicity is a necessity prior to  compounds being tested in animals and clinical trials in 
effort to save resources and time (Gerets et al., 2012). In vitro model systems are often utilised in 
toxicity studies as it allows the study of dose-response relationships, enzyme kinetics, 
mechanisms of toxicity and chemical metabolism (Soldatow et al., 2013). In vitro models have 
many advantages including reduced time requirements, small quantities of reagents are needed, 
number of animal test subjects are reduced as well as the minimised cost of animal care and 
maintenance (Soldatow et al., 2013). 
Hepatocellular carcinoma (HepG2) cells are endothelial cells derived from the liver of a 15 year 
old Caucasian male. They are highly differentiated cells that exhibit many of the genotypic 
characteristics of normal hepatocytes. Hence,  HepG2 cells are considered as a good cell model 
system for studies pertaining to drug design and development, mechanisms underlying 




1.3.4.1 Mediators of inflammation 
Inflammation is a fundamental part of wound healing in response to hepatic injury. Acute 
inflammation is beneficial as it promotes regeneration following traumatic injuries to the liver or 
induces the immune response to target and eradicate abnormal cells. However chronic 
inflammation is pernicious as persistent hepatic injury and its associated regenerative wound 
healing responses lead to the sequential development of fibrosis, cirrhosis and eventually 
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hepatocellular carcinoma (Luedde and Schwabe, 2011; Hoesel and Schmid, 2013; Bishayee, 
2014). The three distinct mediators of inflammation are nuclear factor kappa-light-chain-enhancer 
of activated B cells (NF-kB), interleukin-6 and signal transducer and activator of transcription 3 
(STAT3).   
 
1.3.4.1.1 Nuclear factor kappa -light-chain-enhancer of activated B cells (NF-kB) 
NF-kB  is a dimeric complex consisting of subunits belonging to the Rel family of DNA binding 
proteins: p105/p50, p100/p52, RelB, c-Rel and p65 (RelA) which regulates the transcription of 
genes involved in cell survival, growth and differentiation, immune responses and inflammation 
(Beinke, 2004). NF-kB proteins have the Rel homology domain (RHD) enabling binding to DNA, 
dimerisation and nuclear localisation.   Under normal physiological conditions, subunits p50 and 
RelA of dimerised NF-kB  are cloistered in the cytoplasm by binding to the inhibitor of NF-kB 
(I-kB) proteins which consists catalytic subunits, IKK and IKKβ and a regulatory subunit IKK 
γ/NEMO (Ben-Neriah and Karin, 2011). Upon a specific stimulation such as chemotherapeutic 
agents, stress inducers or cytokines, I-kB is phosphorylated thereby triggering its ubiquitination 
and degradation by the 26S proteasome. Liberated NF-kB  dimer translocates to the nucleus to 
initiate gene transcription by binding to the kB site also identified as the consensus DNA sequence 
5'-GGGRNNYYCC-3' where N is any base, Y indicates cytosine or thymine and R indicates 
adenine or guanine (Antonaki et al., 2011). NF-kB dimerised complex is further regulated by 
protein phosphorylation as well as post translational modifications including protein acetylation. 
It also is responsible for activation of genes involved in cell death inhibition, promotion of 
migration and invasion of transformed cells and tumorigenesis associated mesenchymal stem cell 
formation (Figure 1.5) (Ben-Neriah and Karin, 2011). A possible link between cancer and NF-kB 
first became evident during the cloning of the p65 encoding gene, RelA. It was identified to be 
homologous to v-Rel, a viral oncogene. Constitutively activated NF-kB is observed in most 
lymphoid and solid tumours.  In majority of cancer cells, NF-kB  activation is maintained as a 
response to extracellular stimulus within the tumour microenvironment or through mutations of 
signalling molecules upstream of active NF-kB (Ben-Neriah and Karin, 2011). The RelA and p50 
NF-kB  heterodimeris crucial in the induction of inflammatory response and NF-kB -mediated 




Figure 1.5: The pathway of NF-kB activation (Prepared by author). 
 
1.3.4.1.2 Interleukin-6 
Within the tumour microenvironment, STAT3 activation is dependent on NF-kB. As in most 
tumours, persistent activation of RelA requires continuous STAT3 signalling.  Thus STAT3 
signalling increases NF-kB activity.   This reciprocal relationship existing between STAT3 and 
RelA stems from the fact that growth factors and cytokines encoded by RelA are activators of 
STAT3. The most crucial and important STAT3 activator downstream of NF-kB  is interleukin-
6 (IL-6) (Yu et al., 2009; Wang et al., 2011). Interleukin-6 is a pleiotropic cytokine exhibiting 
both pro and anti-inflammatory characteristics. This cytokine is able to exert its effects on 
different cell populations within the inflammatory and immune systems. IL-6 is functionally 
involved in B cell differentiation, T-cell activation, malignancy development and progression and 
chronic inflammation (Choi et al., 1994; Hunter and Jones, 2015).  
 
1.3.4.1.3 Signal transducer and activator of transcription 3 (STAT3) 
STAT proteins have a central role in cytokine signalling pathways involved in cellular growth, 
proliferation and differentiation. The STAT family comprises of seven members: STAT1, 
STAT2, STAT3, STAT4, STAT5a, STAT5b, and STAT6. A distinguishable feature of STAT 
proteins is their dual role: in the nucleus they function as transcription factors and transduce 
signals through the cytoplasm (Yu et al., 2009). Among the STAT members, STAT3 has garnered 
great interest in regard to its role in oncogenic signalling pathways and its influence in the 
regulation of signal transduction pathways of pro-inflammatory cytokines functional in hepatic 
damage and repair mechanisms (Bishayee, 2014). Inflammation and cancer are interconnected 
through both the intrinsic and extrinsic pathway of STAT3 activation. In transformed cells,  the 
intrinsic pathway also known as the oncogenic pathway is activated by epigenetic or genetic 
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alterations such as persistent activation or overexpression of cytokine receptors with 
accompanying Janus kinase (JAK) family of tyrosine kinases and growth factor receptors with 
intrinsic activity of tyrosine kinase. Inducers of the extrinsic or environmental pathway include 
cigarette smoking, stress, UV radiation or carcinogens (Schmidt-Arras and Rose-John, 2016). The 
IL-6-STAT3 signalling pathways is initially activated by the ligation of IL-6 to its corresponding 
receptor. Signalling is then activated upon IL-6/IL-6R complex association with glycoprotein 
receptor, GP130. The GP130 receptor undergoes dimerisation and in doing so, activates tyrosine 
kinase JAK1 causing the phosphorylation of STAT3 protein (Schmidt-Arras and Rose-John, 
2016). Phosphorylated STAT3 forms dimers and then translocates to the nucleus for direct 
regulation of gene expression cell proliferation, survival, invasion and metastasis. Additionally 
STAT3 induces the expression of inflammatory mediators including cyclo-oxygenase 2, IL-10 
and IL-6, the latter of which results in further activation of STAT3 thus forming an autocrine and 
paracrine feedback mechanism ultimately resulting in alterations of the genetic programme and 
advancement of cancer associated inflammation (Figure 1.6) (Yu et al., 2009). 
 
Figure 1.6: The intrinsic and extrinsic pathway of STAT3 activation linking inflammation and 
cancer (Yu et al., 2009).  
 
Hepatocellular carcinoma as the result of chronic inflammation is mainly induced by viral 
exposures, environmental pollutants, cigarette smoking and alcohol consumption (Aggarwal et 
al., 2006). It has been established that although inflammation aids in immune responses, on a 
chronic level, it appears to have pro-oncogenic properties (Grivennikov et al., 2010). Chronic 
inflammation is responsible for the overproduction of ROS, reactive nitrogen species (RNS), and 
inflammatory cytokines. This excessive production of ROS and RNS can eventually lead to 




1.3.5 Oxidative stress  
1.3.5.1 Reactive oxygen and nitrogen species 
ROS typically exist at low levels in aerobic cells and is formed during the metabolism of 
molecular oxygen (Waris and Ahsan, 2006). However, ROS can also be generated  during 
exposure to ultraviolet (UV) radiation, reactions catalysed by metals or produced by phagocytes 
during inflammation (Waris and Ahsan, 2006; Rahman, 2007).  
 
Mammalian cells depend on the mitochondria to generate energy in the form of ATP through 
oxidative phosphorylation, a process involving the transfer of electrons through the electron 
transport chain (ETC)  (Martinou and Youle, 2011). The ETC is made up of enzyme-dependent 
complexes: complex I (NADH-Q oxidoreductase), II (succinate-Q reductase), III (Q- cytochrome 
c oxidoreductase), IV (cytochrome c oxidase) and V (mitochondrial ATP synthase) (Berg et al., 
2002). Briefly, nicotinamide adenine dinucleotide (NADH) donates a free proton to complex I 
which then transfers it to flavin mononucleotide (FMN) to produce flavin mononucleotide 
(reduced form), during this process electrons are released from NADH. Complex I transfers 
electrons to Flavin-adenine dinucleotide (FAD) from succinate. Electrons from both complexes 
are transferred to complex III via ubiquinone (co-enzyme Q). Ubiquinone carries electrons to 
complex III through redox reactions together with the generation of a proton gradient across the 
inner mitochondrial membrane. Complex IV produces a proton gradient against the 
transmembrane by receiving electrons from cytochrome c. Electrons are received at the active 
sites of complex IV with molecules of iron, copper and haem. Using the proton gradient provided, 
oxygen is reduced to two molecules of water by complex IV and ATP is synthesised from 
adenosine diphosphate (ADP) and orthophosphate (Pi) through complex V(Figure 1.7) (Berg et 
al., 2002).  
 
 
Figure 1.7: Representation of the mitochondrial electron transport chain (Nussbaum, 2005). 
 
Within living cells, the main source of ROS is superoxide anion and hydrogen peroxide, both of 
which are produced as by-products of mitochondrial respiration (Waris and Ahsan, 2006). These 
highly reactive molecules have a dual effect as they can either be beneficial or harmful.  When 
tightly regulated, ROS can provide added defence against infectious substances and is a functional 
component of cell to cell communication systems, however during adverse conditions, the balance 
between ROS and their elimination may be disrupted causing a significant increase in the level of 
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ROS, mediating damage to cellular membranes, lipids and proteins. This damage is classified as 
“oxidative stress” (Wei et al., 2000; Rahman, 2007).  DNA damaged induced by ROS has been 
widely recognised as a major cause of cancer (Waris and Ahsan, 2006). 
Reactive nitrogen species (RNS) is another variation of oxidants derived from nitric oxide (NO), 
which include nitrogen dioxide (NO2), peroxynitrite (ONOO-),  nitrosoperoxycarbonate 
(ONOOCO2-) (Nash et al., 2012). A reaction between O2- and NO2 actively generates ONOO- 
and is deemed the most highly reactive RNS. It is primarily responsible for the oxidative and 
nitrative damage to biological cellular components including proteins, lipids and DNA (Dedon 
and Tannenbaum, 2004).  
 
1.3.5.2 Consequence of oxidative stress 
In pathological conditions, ROS and RNS are generated at a substantially higher rate than in the 
normal physiological state, and as a consequence, lipid peroxidation occurs. Lipid peroxidation 
is initiated by abstraction of hydrogen atoms from lipids containing two or more carbon atoms or 
by the addition of oxygen radicals resulting in undue oxidative damage towards polyunsaturated 
fatty acids (PUFAs) (Halliwell, 2006; Repetto et al., 2012; Ayala et al., 2014).  This results in a 
single unpaired electron on the carbon atom forming a “carbon-centred radical” (Repetto et al., 
2012). The lipid radical firstly undergoes a molecular rearrangement to stabilise the double carbon 
bonds and then subsequently reacts with O2 to form peroxyl radicals. The peroxyl radical by itself, 
is capable of removing a hydrogen atom from another PUFA and so starts a chain reaction 
(Repetto et al., 2012). Peroxyl radicals readily attack adjoining side-chains and mediate the 
oxidation of proteins within the cell membrane  (Halliwell, 2006) leading to the eventual 
destruction of the lipid membrane accompanied with the generation of a variety of decomposition  
products including ethers, aldehydes ketones and hydroperoxides which exerts genotoxic and 
cytotoxic effects (Esterbauer, 1993; Niki et al., 2005; Repetto et al., 2012). Lipid peroxidation, is 
thus the main molecular mechanism responsible for cellular oxidative damage and through the 
toxicity process, it is capable of inducing cell death (Repetto et al., 2012; Ayala et al., 2014). 
 
1.3.6 Fate of the cell 
1.3.6.1 Poly (ADP-ribose) polymerase 
DNA damage is repaired by numerous proteins including those that cause cell death to prevent 
the future transmission of mutations or disrupt the cell cycle. Poly (ADP-ribosyl)ation is a post-
translation modification of nuclear proteins consisting of the synthesis of ADP-ribose polymers 
on target proteins, in response to DNA damage. Synthesis of poly (ADP-ribose) is solely carried 
out by members of the poly (ADP-ribose) polymerase family but majority is by the most active 
and abundant member, poly (ADP-ribose) polymerase-1 (PARP-1). PARP-1 is a 113 kDa, zinc 
fingered protein consisting of 1014 amino acids. It has been implicated in several biological 
cellular processes including genome stability, DNA transcription, replication and repair, 
signalling for degradation of protein, energy source required for base excision repair and 
regulation of telomerase activity. Typically, in the absence of DNA damage, poly (ADP-
ribosyl)ation levels are relatively low in the absence of DNA damage however in response to 
double or single stranded DNA breaks, PARP-1 becomes rapidly activated.  In response to DNA 
strand breaks, PARP-1 becomes active and subsequently prompts poly (ADP-ribose) synthesis at 
the expense of nicotinamide adenine dinucleotide (NAD+) which is cleaved into nicotinamide and 
ADP-ribose. On the target acceptor protein, PARP-1 catalyses ADP-ribose binding at the 
glutaminic residue thereby facilitating the elongation and branching of the protein. Inversely, 
decreased levels of NAD+ results in an unbalanced NAD+/NADH ratio which affect the Kreb’s 
cycle, pentose shunt and glycolysis due to aberrant activation of enzymes. The redox state of cells 
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are also significantly altered as the cell attempts to revive the NAD+ stores by recycling 
nicotinamide with two ATP molecules. However during this process, excessive PARP-1 
activation leads to the depletion of intracellular ATP and NAD+. As a result, majority if not all 
energy-dependent cellular processes are suddenly disrupted. Therefore, in incidences of 
widespread DNA damage, excessive poly(ADP-ribose) synthesis drives the cell to its death 
(Bouchard et al., 2003). During apoptosis, executioner capase 3/7 cleaves PARP-1 into two 
fragments, an 89 kDa and 24 kDa fragment. This cleavage prevents the repair of DNA strand 
breaks, ultimately resulting in cell death (Erener et al., 2012). 
 
1.3.6.2 Apoptosis: Programmed cell death 
Multicellular organisms maintain their functionality through the regulation of homeostasis and 
developmental processes by maintaining the appropriate balance between cell proliferation and 
death. Billions of cells on a daily basis undergo programmed cell death as it allows the cell 
numbers to be closely regulated (Hengartner, 2000; Sreelatha et al., 2011; Govender, 2012). 
Apoptosis is a process by which cells are extracellularly or intracellularly signalled to their demise 
as a cellular defence mechanism used to eliminate cells damaged by toxic agents, normal 
metabolic processes or disease (Elmore, 2007; Sreelatha et al., 2011). Apoptotic cell death is 
energy-dependent and consists of an orchestrated set of events involving multiple caspase 
activation and a multiplex cascade that relates the initial stimuli to the death of the cell (Elmore, 
2007). Intracellular caspases are cysteine-rich proteases that govern programmed cell death (Circu 
and Aw, 2010; Govender, 2012). They are synthesised as procaspases and require proteolytic 
cleavage for activation (Ashe and Berry, 2003). In humans, more than twelve caspases have been 
identified and about two thirds have been involved in the function of apoptosis (Hengartner, 
2000). Caspases are classified into two groups: initiators and executioners (Govender, 2012). 
Both of the caspase groups, the initiator caspases (caspases 8 and 9) become activated through 
homodimerisation and they subsequently cleave and activate the executioner caspases (caspase 3 
and 7). Caspase 3/7 are responsible for the morphological changes characteristic of apoptotic cell 
death, such as shrinkage of cells, chromatin condensation, DNA fragmentation, membrane 
blebbing and apoptotic body formation (Hengartner, 2000; Circu and Aw, 2010; Govender, 2012). 
Apoptosis is divided into two pathways: extrinsic and intrinsic but ultimately both pathways 
converge to execute the final phase of cell death (Elmore, 2007). The extrinsic apoptotic pathway 
is activated through death receptor-ligand binding. The intrinsic pathway initiates apoptosis 
through a variety of stimuli including hypoxia, radiation, growth factor deprivation, DNA damage 
or oxidative stress (Mukhopadhyay et al., 2014).  
 
1.3.6.2.1 Extrinsic apoptosis: Death-receptor mediated pathway 
The extrinsic pathway is induced by the interaction between the Tumour necrosis factor (TNF) 
superfamily and a specific associated ligand. FAS (CD-95), TNF receptor 1 (TNFR1), TNF-
related apoptosis-inducing ligand-receptor 1 and 2 (TRAIL 1 and 2) are the most understood and 
best characterised members of the TNF superfamily (Ashe and Berry, 2003). Ligation of TNFR1 
and TNF- α causes the trimerisation of the death receptor followed by the clustering of the death 
domains (DD) (Ashe and Berry, 2003; Elmore, 2007). The DD transmits a death signal from the 
cellular surface to the signalling pathways within the cell. TNFR1- associated death domain 
(TRADD) is recruited and binds to the DD followed by FAS-associated death domain (FADD) 
and receptor-interacting protein (RIP). FADD contains a death effector domain (DED) that 
associates with procaspase 8 via dimerization and the death inducing signalling complex (DISC) 
is then formed. This results in procaspases 8 being auto-catalytically cleaved for activation 
thereby triggering the execution step of apoptosis involving the cleavage and activation of 
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executioner caspases 3 and 7 (Figure 1.8). Caspase 8 also relays a signal to the mitochondria via 
BH3- only protein, cytosolic Bid. Caspase 8 cleaves Bid to form truncated Bid (tBid) which then 
translocates to the mitochondria from the cytosol and induces the release of cytochrome c (Wang, 
2001). Cellular flice inhibitory protein (c-FLIP) binds to FADD and procaspase 8 rendering them 
inept, DISC is ineffective and apoptosis is thus inhibited (Elmore, 2007).  
 
Figure 1.8: Extrinsic and intrinsic induction of apoptosis (Yuan et al., 2012). 
 
1.3.6.2.2 Intrinsic apoptosis: Mitochondrial- mediated pathway 
The intrinsic pathway is initiated through several stimuli that generate intracellular signals which 
act specifically on targets within the cell, which is mediated by the mitochondria (Elmore, 2007). 
The mitochondria have a fundamental role in apoptotic cell death as it releases key proteins 
functional in apoptosis from its intermembrane space (Kuwana and Newmeyer, 2003). The Bcl-
2 family of proteins regulate apoptosis through mitochondrial permeabilisation. Bax and Bak are 
apoptotic proteins that belong to the Bcl-2 family. Once a death stimulus is received, Bax 
experiences conformational modifications and incorporates itself into the outer mitochondrial 
membrane (Figure 1.8). Oligomerisation of Bak and Bax permeabilises the outer mitochondrial 
membrane to facilitate the release of the pro-apoptotic proteins from the mitochondria. Bcl-2, Bcl-
xL and Mcl-1 are anti-apoptotic proteins also belonging to the Bcl-2 family (Hunter et al., 2007).  
The initiating stimuli cause the inner mitochondrial membrane to change its morphology resulting 
in the mitochondrial permeability transitional pores opening, membrane potential is reduced and 
two groups of pro-apoptotic proteins are released from the mitochondria into the cytosol. The first 
group includes cytochrome c and second mitochondria-derived activator of caspases/DIABLO 
(Smac/DIABLO) both of which activates the intrinsic pathway. Cytochrome c binds to the adaptor 
protein apoptotic protease activating factor-1 (Apaf-1) in the cytosol, numerous procaspase 9 
molecules are recruited to the caspase recruitment domain (CARD) of Apaf-1 resulting in 
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apoptosome formation (Wang, 2001; Elmore, 2007). Apaf-1 undergoes conformational changes 
and activation by ATP hydrolysis (Kim et al., 2005). Apoptosis is promoted by Smac/DIABLO’s 
ability to inhibit inhibitors of apoptosis proteins (IAP). Procaspase 9 homodimerisation leads to 
the activation of caspase 9. Apoptotic-inducing factor (AIF), endonuclease G and caspase DNase 
(CAD) form part of the second group of pro-apoptotic proteins released from the mitochondria 
during the latter stages of apoptosis. AIF translocates to the nucleus for the induction of peripheral 
nuclear chromatin condensation and chromosomal cleavage. Endonuclease G translocates to the 
nucleus where it induces nuclear chromatin cleavage resulting in fragmentation of DNA. 
Mitochondrial-released CAD translocates to the nucleus and is subjected to cleavage by caspase 
3 after which it actively participates in advanced chromatin condensation and DNA fragmentation 
(Elmore, 2007). 
 
1.3.6.2.3 Execution of cell death  
The extrinsic and intrinsic pathways come together to activate the execution phase of apoptosis. 
Caspase 3 and 7 activates the cytoplasmic endonuclease and proteases for the degradation of 
cytoskeletal proteins and nuclear material (Figure 1.8). Caspase 3 is considered the most 
important of all executioner caspases. In normal dividing cells, CAD forms a complex with an 
inhibitor of CAD (ICAD), caspase 3 releases CAD in apoptotic cells by cleaving ICAD. 
Furthermore caspase 3 causes reorganisation of the cytoskeletal structure and the disintegration 






CHAPTER 2  
Materials and Methods 
2.1 Materials:  
MO leaves were obtained from the KwaZulu-Natal region (Durban, South Africa (SA)) and 
verified by the KwaZulu-Natal herbarium (Genus no. 3128). The HepG2 cells were purchased 
from Highveld Biologicals (Johannesburg, SA). Cell culture reagents were purchased from Lonza 
Biotechnology (Basel, Switzerland). Western blot reagents were purchased from Bio-Rad 
(Hercules, CA, USA). CellTiter-Glo®, P450-Glo™ and Caspase-Glo® 3/7, 8 and 9 luminometry 
assays were purchased from Promega. Western blot reagents were purchased from Bio-Rad 
(USA).  All other reagents and consumables were purchased from Merck (Darmstadt, Germany). 
 
2.2 Leaf extract preparation 
To prepare the MO leaf extract (MOE), 10 g of air-dried leaves was crushed and 100 ml de-
ionised water was added. The mixture was then boiled with continuous stirring for 20 min. The 
mixture was transferred to 50 ml conical tubes and centrifuged (720 × g, 10 min, room 
temperature (RT)). The upper aqueous layer (MOE) was aspirated, lyophilised and stored (4°C) 
until use. MOE stock solution was prepared (1 mg of MOE was dissolved in 1 ml of CCM) and 
filter sterilised (0.45 μM filter (Millipore).  
 
2.3 Cell culture and treatment 
The HepG2 cells were cultured (37°C, 5%, CO2) in 25 cm3 culture flasks in complete culture media 
(CCM) comprised of Eagle’s minimum essential medium supplemented with 1% L-glutamine, 
1% penicillin-streptomycin-fungizone and 10% fetal bovine serum. Cell growth was monitored 
and CCM was changed as necessary. Confluent flasks were trypsinized using 1 ml trypsin and 
cell numbers were enumerated using trypan blue. Following the determination of the 
concentration of half maximum inhibition (IC50), all treatments for subsequent assays were 
conducted in 25 cm3 cell culture flasks for duration of 72 hours (h). For the 72 h exposure, 
treatment culture medium was replenished every 24 h. 
 
2.4 MTT Assay 
2.4.1 Introduction 
The 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MTT) assay is a 
colorimetric method used to assess cell viability and proliferation. This technique is based on the 
reduction of MTT, a water-soluble yellow tetrazolium dye by viable cells to an insoluble formazan 
product. MTT enters the cell and it is reduced by NAD(P)H-dependent mitochondrial 
dehydrogenases resulting in the formation of an intracellular purple formazan product and 
reducing equivalents NAD+/ NADP+/ FAD+. The purple formazan product is then solubilised 
using an organic solvent and quantified with an absorbance of 570 nm (Figure 2.1). The amount 
of formazan produced is directionally proportional to the number of viable cells (Mosmann, 1983; 




Figure 2.1: Reduction of MTT yellow salt to insoluble purple formazan by metabolically active 
cells [Adapted from (Riss et al., 2015)]. MDH: mitochondrial dehydrogenase. 
 
2.4.2 Protocol 
The cytotoxicity of MOE in HepG2 cells was measured by the MTT assay. Cells (10 000 
cells/well) were seeded in a 96-well microtitre plate and allowed to attach overnight (37°C, 5% 
CO2). Cells were then incubated with varying MOE concentrations (0, 250, 500, 1 000, 1 500, 2 
000, 3 000, 4 000 μg/ml) in triplicate (300 μl/well) and incubated (37°C, 5% CO2) for 72 h. 
Following incubation, cells were rinsed once with 0.1M phosphate buffer saline (PBS) and 
incubated with a MTT salt solution (5 mg/ml in 0.1 M PBS) and CCM (120 μl/well) for 4 h. 
Thereafter, supernatants were removed and cells were incubated in dimethyl sulphoxide (DMSO; 
100μl/well) for 1 h. The optical density (OD) of the formazan product was measured at 570 nm, 
with a reference wavelength of 690nm by an enzyme-linked immunosorbent assay (ELISA) plate 
reader (BioTek μQuant, USA). The cell viability percentage was calculated by utilising the 
equation below and a concentration-response curve was plotted using GraphPad Prism V5.0 
software (GraphPad Software Inc., La Jolla, USA). Each experiment was conducted twice on 
separate occasions to determine the IC50. For all subsequent assays, HepG2 cells were treated at 
70% confluency with the determined IC50. 
% Cell viability = 
mean absorbance of treated cells
mean absorbance of control cells




2.5 ATP assay 
2.5.1 Introduction 
Adenosine triphosphate (ATP) is a nucleoside triphosphate, functional in energy exchange within 
biological systems. All metabolically active cells require ATP for survival and to appropriately 
execute cellular functions thus quantification of ATP serves as a useful tools in determining cell 
viability and cytotoxicity (Crouch et al., 1993).  ATP is produced via cellular respiration and 
glycolysis however it can also be generated through the electron transport chain, Kreb’s cycle and 
pyruvate oxidation. It is already well established that the main contributor to ATP production is 
the electron transport chain via oxidative phosphorylation within the mitochondria (Riss et al., 
2015). 
The ATP quantification assay adapts bioluminescence to determine ATP levels in cells. The assay 
is based on the ATP dependent conversion of a luciferase-inactive derivative in the presence of 
Mg2+ to a luciferase substrate, D-luciferin. D-luciferin readily reacts with the enzyme luciferase 
to produce oxyluciferin whilst in the process energy is released in the form of luminescence. The 




Figure 2.2: Bioluminescent reaction catalysed by luciferase in the presence of ATP, magnesium 





Adenosine triphosphate (ATP) levels were quantified by the CellTiter-Glo® luminescent assay 
(Promega, Madison, Wisconsin, USA). Reagents were prepared according to manufacturer’s 
instructions. Following treatment, cells were washed (3x), trypsinised and seeded into a white 96-
well luminometer plate in triplicate (20,000 cells/well), followed by the addition of 20 l of the 
CellTiter-Glo® reagent. The plate then incubated in the dark (RT; 30 min). Following incubation, 
luminescence was measured on a Modulus™ microplate luminometer (Turner BioSystems, 
Sunnyvale, California, USA). Data obtained was expressed as relative light units (RLU).  
 
2.6 Cytochrome P450 3A4 activity 
2.6.1 Introduction 
Cytochrome P450 enzymes are a superfamily consisting of hemeproteins, responsible for 
metabolism of xenobiotics and endogenous compounds.  CYP3A4 is the most abundantly 
expressed member of the superfamily and is the main enzyme involved in hepatic drug 
metabolism, approximately 60% of all pharmaceutical drugs (Basheer and Kerem, 2015). 
The P450-Glo™ 3A4 assay utilises luminescence to provide a simple method for CYP3A4 activity 
quantification. The assay is based on the conversion of CYP3A4 substrate, a luciferase-inactive 
D-luciferin derivative, by CYP3A4 to D-luciferin. Released D-luciferin reacts with luciferase to 
generate a luminescent signal. The luminescent signal is directly proportional to CYP3A4 activity 
(Figure 2.3) (Cali et al., 2006).  
 





The P450-Glo™ assay kit was obtained from Promega (Madison, USA). Dexamethasone [Sigma-
Aldrich (St. Louis, MO, USA)] is a known inducer of CYP3A4 activity and was used as a positive 
control according to manufacturer’s guidelines. The luciferin-PFBE substrate and luciferin 
detection reagent were prepared prior to the assay according to the manufacturer’s guidelines. 
Following MOE treatment, cells were washed (3x), trypsinised and seeded into a white 96-well 
luminometer plate (20,000 cells/well) in triplicate with 5 μl luciferin-PFBE substrate and 
incubated (37 °C; 4 h). Thereafter, 50 l of luciferin detection reagent was added and the plate 
was incubated in the dark (RT; 20 min). Luminescence was measured on a microplate 
luminometer (Turner Biosystems, USA). Results were expressed as RLU.  
 
2.7 Lipid peroxidation 
2.7.1 Introduction 
Lipid peroxidation is a process in which oxidants including non-radical and free radical species 
react with lipids that contain one or more carbon-carbon double bond, particularly susceptible to 
such reactions are  polyunsaturated fatty acids (PUFAs) (Yin et al., 2011). The overall process of 
lipid peroxidation consists of three steps: initiation, propagation and termination. Initiation results 
in the generation of lipid free radicals. The free radicals react with PUFAs to yield a second free 
radical. The free radicals are then free to react with the surrounding PUFAs leading to propagation 
of the chain reaction. Propagation will take place until two free radicals conjugate with one 
another, producing an end product to terminate the chain reaction (Repetto et al., 2012). One end 
product commonly used as the biomarker for lipid peroxidation is Malondialdehyde (MDA) 
(Ayala et al., 2014). 
The thiobarbituric acid reactive substances assay provides a quantitative method to measure MDA 
concentration. It is fundamentally based on the reaction between MDA and thiobarbituric acid 
(TBA) butylated hydroxytoluene (BHT). MDA readily reacts with TBA to produce a red, 




Figure 2.4: Schematic representation of TBARS reaction between MDA and TBA/BHT 
[Adapted from (Janero, 1990)]. 
 
2.7.2 Protocol 
The Thiobarbituric Acid Reactive Substances (TBARS) assay was used to assess the oxidative 
damage incurred by MOE on HepG2 cells. TBARS measures MDA, an end product of lipid 
peroxidation. Following MOE treatment, supernatant from samples (200 μl) were aliquoted, in 
duplicate, into clean glass test tubes, followed by the sequential addition of 2% phosphoric acid 
(200 μl), 7% phosphoric acid (400 μl) and TBA/BHT solution (400 μl). MDA served as a positive 
control. All samples were adjusted to pH 1.5 and boiled for 15min to allow for the reaction occur 
(Figure 2.4). Once cooled to RT, butanol (1.5 ml) was added to each test tube, vortexed and 
allowed to separate into distinct phases. The upper butanolic phase (800 μl) was transferred into 
micro-centrifuge tubes and centrifuged (13200 rpm, 6 min, RT). Each sample was aliquoted into 
a 96-well microtitre plate in triplicate (100 μl/well). Optical density was measured using a 
spectrophotometer at 532 nm with reference wavelength of 600 nm (BioTek μQuant, USA). The 
assay was completed on three separate occasions to determine MDA levels. The sample means 
were calculated and divided by the absorption coefficient, 156 mM-1 to yield the mean MDA 
concentration (μM). 
 
2.8 Nitrates and nitrites assay 
2.8.1 Introduction 
Endogenous Nitric oxide (NO) is produced from L-arginine by nitric oxide synthases (NOS) and 
plays important role in the modulation of inflammation, immune response and cell 
communication. NO is an unstable diatomic free radical with an extremely short half-life.  It 
undergoes rapid oxidative degradation to form stable metabolite products, nitrate (NO3-) and 
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nitrite (NO2-).  NO is shortly lived and therefore cannot be appropriately and efficiently quantified, 
so its metabolites are used for the colorimetric indirect determination of NO. This  allows for an 
accurate and sensitive method of identifying the overall NO status in the sample of interest (Bryan 
and Grisham, 2007).  
In the colorimetric assay, vanadium (III) chloride (VCl3) is used to catalyse the reduction of NO3- 
to NO2- which is then quantified by the Griess reaction (Figure 2.5). 
 
Figure 2.5: The Griess Reaction [Adapted from (Tarpey et al., 2004)]. This involves a two-step 
diazotisation reaction, NO2- reacts with sulphanilamide (SULF) to produce a diazonium cation 
which couples to N-(1-napthyl)ethylenediamine (NEDD) to form a red-violet chromophoric diazo 
product (Tsikas, 2007). 
 
2.8.2 Protocol 
The nitrates and nitrites assay was used to quantitate the effect of MOE on NO production in 
HepG2 cells. Proceeding MOE treatment, supernatant from samples and standards (0, 3.125, 6.25, 
12.5, 25, 50, 100, 200 μM) (50 μl) were aliquoted, in triplicate, into a 96 well microtitre plate, 
VCl3 (50 μl), SULF (25 μl) and NEDD (50 μl) were sequentially added to all wells and the plate 
incubated (dark, 30 min, 37ºC). Absorbance was measured at 540 nm with reference wavelength 
690 nm. Standard means were used to generate a standard curve which was used to determine the 
nitrates and nitrite levels in the samples. Data was represented as μM. 
 
2.9 LDH Assay 
2.9.1 Introduction 
Lactate dehydrogenase (LDH) is a stable cytosolic enzyme present in almost all mammalian cell 
types (Chan et al., 2013).  During anaerobic glycolysis, lactate is subjected to an oxidation 
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reaction catalysed by cytosolic LDH and co-enzyme nicotinamide-adenine dinucleotide (NAD+) 
to form pyruvate and NADH. The re-oxidation of NAD+ is very important as it ensures the 
concentration of NAD+ is adequately high to sustain the glycolytic flux. Cell damage due to 
intercellular signals, stress or injuries results in the rapid release of LDH from the cell membrane 
into the extracellular medium (Figure 2.6). Thus, measurement of the extracellular LDH levels 
serves as a biochemical marker for cytoxicity and cell death (Fiume et al., 2014). 
The LDH assay consists of a two-step process involving the enzymatic reaction whereby NAD+ 
is reduced to NADH/H+ by the oxidation of lactate to pyruvate. Thereafter, phenazine 
methosulphate (PMS) or diaphorase catalyst transfers H/H+ from NADH/H+ to a tetrazolium salt 
to yield a formazan product (Chan et al., 2013). 
 
 
Figure 2.6: Schematic representation of LDH release from a damaged cell [Adapted from 
(Forest et al., 2015)]. 
 
2.9.2 Protocol 
LDH activity was measured using the Lactate Dehydrogenase (LDH) cytotoxicity detection kit 
(11644793001) (Roche, Mannheim, Germany).  Sample supernatants (100μl) were transferred, in 
triplicate, into a 96-well microtitre plate. Thereafter, substrate mixture (100μl) containing catalyst 
(diaphorase/NAD+) and dye solution (INT/sodium lactate) was added into each well and allowed 
to react (25 min, RT). A formazan product was formed and optical density was measured at 
500nm with an ELISA plate reader (BioTek μQuant, USA). The data obtained was represented 




2.10 ELISA assay 
2.10.1 Introduction 
The Enzyme-Linked Immunosorbent Assay (ELISA) is a biochemical method for the qualitative 
or quantitative detection of analytes such as cytokines. This assay is based on the specific binding 
between an antigen and its antibody (Cox et al., 2014). The sandwich ELISA was used to quantify 
cytokine concentrations.  
Briefly, wells of an ELISA microtitre polystyrene plate are coated with cytokine antibodies. When 
the sample is added, the cytokines interact with their corresponding antibodies and form 
complexes. Once the enzyme-conjugate secondary antibodies are added, they bind to the cytokine. 
The Streptavidin-HRP working solution is responsible for the substrate that ultimately produces 
colour (Figure 2.7). The colour intensity is directly proportional to the amount of cytokines 
present in the samples (Cox et al., 2014).  
 
Figure 2.7: Sandwich ELISA [Adapted from (Cox et al., 2014)]. Post coating of wells, analytes 
binds to their respective antibodies, the biotinylated secondary antibodies are added and bind to 
the analytes. This is followed by the interaction of the streptavidin labelled enzyme to the biotin 
molecule. Lastly, an enzyme substrate is added and subsequently converted to generate a colour 
directly proportional to the cytokine concentration (Cox et al., 2014). 
 
2.10.2 Protocol 
The sandwich ELISA was used for the detection of the following cytokines IL-6, IL-10, TNF- 
and IL-1β. A 96-well ELISA plate was coated with 100 μl Capture Antibody (cytokine antibody) 
diluted in Coating Buffer and incubated overnight (4°C). Coated wells were aspirated, washed 
thrice with 300 μl wash buffer and blocked with 200 μl Assay Diluent (RT, 1 h). After blocking, 
wells were aspirated and washed thrice with wash buffer (300 μl). Sample and standard dilutions 
were prepared in Assay Diluent and 100 μl of each was subsequently added to the wells and 
incubated (RT, 2 h). Wells were aspirated and washed five times (300 μl), 100 μl Working 
Detector was then added into each well and the plate incubated (RT, 1 h). The Working Detector 
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was aspirated and the plate washed seven times (300 μl). After the seventh wash, 100 μl of 
Substrate Solution was added and incubated (dark, RT, 1 h). Finally, 50 μl Stop Solution was 
added to each well and the optical density (OD) was measured at 450 nm, with a reference 
wavelength of 570 nm by an enzyme-linked immunosorbent assay (ELISA) plate reader (BioTek 
μQuant, USA). Data was represented as picograms per ml (pg/ml).  
 
2.11 Caspase activity 
2.11.1 Introduction 
Caspases are a family of cysteine proteases that have a central role in the initiation and execution 
of programmed cell death. Caspases are expressed in all types of cells and are initially produced 
as  inactive zymogens, only once an apoptotic signal is received, does activation occur (McIlwain 
et al., 2013).  
Luminometric caspase activity assay is used to quantify caspase activation. This assay involves 
luminogenic substrate conjugated aminoluciferin cleavage by the caspase. The aminoluciferin 
serves as the luciferase substrate, upon its release; it reacts with luciferase in the presence of ATP 
and molecular oxygen to generate a luminescent signal (Figure 2.8). This luminescent signal is 




Figure 2.8: Bioluminescent quantification of caspase 8, 9 and 3/7 activity [Adapted from 
(Brunelle and Zhang, 2010; Riss et al., 2015)]. X represents the peptide sequence: LETD (caspase 




Caspase-Glo® 8 (G88201) and Caspase-Glo® 9 (CG8211) and Caspase-Glo® 3/ 7 (G8092) was 
used to assess apoptosis (Promega, Madison, USA). Reagents were prepared according to 
manufacturer’s guidelines. MOE treated and untreated cells were added to wells of a white 96-
well microtitre plate in triplicate (20,000 cells in 50 μl 0.1M PBS/well). Caspase reagent (20 μl) 
was added and incubated in the dark (30 min, RT). The luminescent signal was measured on a 
Modulus™ microplate luminometer. The assay was conducted on three separate occasions to 
determine caspase activities and results were expressed as relative light units (RLU).  
 
2.12 Single cell gel electrophoresis (SCGE) assay 
2.12.1 Introduction 
Single cell gel electrophoresis (SCGE), best known as the comet assay, is a simple, rapid  
technique used to detect DNA damage in cells in response to genotoxic stimuli (Collins, 2004; 
Liao et al., 2009). The comet assay is based upon the quantification of DNA fragments migrating 
from the cell’s nucleus during electrophoresis. DNA fragmentation is regarded as a biochemical 
hallmark of late apoptosis and is facilitated by  proteins induced downstream of the apoptotic 
cascade (Matassov et al., 2004; Olive and Banáth, 2006). Initially, it could only be used to detect 
double stranded DNA breaks however in 1988, Singh et al. optimised the protocol in alkalinic 
conditions to not only allow for the detection of  double stranded DNA breaks but also DNA 
single stranded breaks and alkali-labile sites ( Singh et al, 1988; Liao et al., 2009). The alkalinic 
comet assay involves cells embedded in agarose gel which thereafter are immersed in lysis buffer. 
The damaged DNA strands released during cell lysis yield the comet tail following 
electrophoresis. Undamaged DNA does not migrate and remains intact in the comet head (Figure 
2.9) (Choucroun et al., 2001). 
 
Figure 2.9:  Formation of comet tails after electrophoresis (Kumar et al., 2012). A. The head of 
the comet contains intact, undamaged high molecular weight DNA. B. If breaks are present in the 
DNA, the DNA supercoil becomes relaxed allowing the smaller DNA fragments to migrate out 
of the nucleus during an applied current thus forming a ‘tail’. Comet tail length indicates extent 
of DNA damage (Olive and Banáth, 2006). 
 
2.12.2 Protocol 
The comet assay was used to determine DNA fragmentation in MOE treated cells. Briefly, three  
microscope slides were prepared per control and treatment with a first layer containing 700 μl of 
2% low melting point agarose (LMPA, 37°C) which were incubated (10 min, 4°C), a second layer 
of 25 μl of cell suspension (20,000 cells suspended in 0.1 M PBS) from each sample with 175 μl 
1% LMPA (37°C), and 1 μl GelRed ™ Nucleic Acid Gel Stain (Biotium, California, 41003) 
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which was allowed to solidify (10 min, 4°C). A third layer containing 200 μl of 1% LMPA (37°C) 
was then added and incubated (10 min, 4°C). Cover slips were removed and slides were 
submerged in cold cell lysis buffer (2.5 M NaCl, 100 mM EDTA, 1% Triton X-100, 10 mM Tris 
(pH 10) and 10% DMSO) (4°C, 1 hr). The slides were equilibrated in electrophoresis buffer (300 
mM NaOH, 1 mM Na2EDTA, pH 13; 20 min) then electrophoresed (300 mA, 25 V, 35 min) after 
which slides were washed three times (0.4 M Tris, pH 7.4, 5 min). Cover slips were placed onto 
slides and viewed using a fluorescent microscope (Olympus IX51 inverted microscope 510-560 
nm excitation and 590 nm emission filters). Images were captured and comet tails of 50 cells were 
measured using Life Science-Soft Imaging System (analySIS® v5). The results were expressed 
as mean comet tail length (μm). 
 
2.13 Hoechst assay 
2.13.1 Introduction 
Hoechst 33342 is a permeable blue fluorescent nucleic dye that’s used extensively in fluorescent 
microscopy. Hoechst has the ability to pass through intact cell membranes and bind to the minor 
grooves in the DNA double helix, specifically to adenine-thymine-rich regions (Figure 2.10). The 
nucleic dye aids in the visualisation and identification of morphological characteristics associated 
with normal cell cycle and apoptosis using fluorescent microscopy (Chazotte, 2011).  
 
 




Hoechst 33342 stain was used to assess the effect of MOE on nuclear material. Cells were seeded 
(300 000 cells/well) into a 6 well plate and treated in triplicate for 72 h.  Cells were washed 3 
times with 0.1 M PBS and fixed with 10% paraformaldehyde for 5 min. After fixation, cells were 
washed with 0.1 M PBS and the Hoechst working solution was added (5 μg/ml, Molecular probes, 
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Eugene, OR) and incubated (15 min, 37°C) Images were captured using a fluorescent microscope 
(Olympus IX51 inverted microscope using 350 nm excitation and 450 nm emission filters). Three 
images per treatment replicate were captured at 20x and 40x magnification. 
 
2.14 Western Blot 
2.14.1 Protein preparation 
Protein from cells was isolated using Cytobuster™ reagent (Novagen) supplemented with 
phosphatase and protease inhibitors (Roche, 04906837001 and 05892791001respectively). 
Cytobuster (200 μl) was added to the cells and incubated on ice (30 min) and subsequently 
centrifuged (10 000 xg; 4°C, 10 min) to obtain a crude protein extract. Following protein isolation, 
crude extracts were quantified and standardised using the bicinchoninic acid (BCA) assay (Sigma, 
Germany).  The BCA assay principle is based on the Biuret reaction. The Biuret reaction measures 
the conversion of Cu2+ to Cu+.  In alkaline conditions, Cu2+ ions reacts with peptide bonds to form 
Cu+, which in turn reacts with BCA to produce an intense purple coloured product quantified at 
562 nm. Protein quantification is necessary in order to determine the concentration of proteins 
present within the samples. Protein standards (0; 0.2; 0.4; 0.6; 0.8, 1 mg/ml) were prepared using 
bovine serum albumin (BSA). Both the protein standards and samples were plated (25 µl). The 
plate was then incubated (30min, 37°C) and the absorbance was measured using the ELISA plate 
reader (BioTek μQuant, USA). The absorbance generated from the standards was used to create 
a standard curve to determine protein concentrations of the samples which were subsequently 
standardised to 1.5 mg/ml in Cytobuster. Standardisation of proteins is essential, as it ensures 
each well contains the same concentration and volume of sample thereby providing an accurate 
comparison of the protein expression. Once the proteins were standardised, samples were 
prepared with Laemmli buffer containing Tris-HCl, SDS, bromophenol blue, β-mercaptoethanol 
and glycerol. Tris-HCl is used as buffer to maintain correct pH range of the sample. Sodium 
dodecyl sulphate is an anionic detergent capable of protein denaturation through the formation of 
micelles around the polypeptide. A negative charge is generated which enables the migration of 
the protein in the gel, during an applied electric field, toward a positive electrode. Bromophenol 
blue is a tracker dye used to monitor protein migration during electrophoresis, β-mercaptoethanol 
breaks disulphide bonds to facilitate band separation in accordance to molecular size and weight 
and lastly, glycerol adds density to the sample allowing the sample to sink to the bottom of the 
well, reducing the occurrence of sample dissemination between wells. Samples were then 
denatured by boiling for 5min at 100 ºC with a 1:4 dilution of 5 x Laemmli sample buffer [0.5 M 
Tris-HCL (pH 6.8); 10% SDS; 2%  bromophenol blue; 12% β-mercaptoethanol  and 3% glycerol 
in dH2O]. 
 
2.14.2 Electrophoresis and Transfer 
After sample preparation, Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-
PAGE) is used to separate the proteins based on molecular size. SDS-PAGE gels were prepared 
using a gel cassette with glass plates. The higher concentration resolving gel is added first 
followed by the lower concentration stacking gel. A 10% SDS-polyacrylamide resolving gel and 
a 4% stacking gel was prepared [10% SDS, Tris, Bis-Acrylamide, dH2O, 10% Ammonium 
persulfate (APS), TEMED]. TEMED activates bis-acrylamide, which acts as a cross linking agent 
that facilitates the polymerisation of the acrylamide gel to create a porous matrix through which 
the proteins can migrate. APS is an oxidising agent used in conjunction with TEMED to facilitate 
bis-acrylamide polymerisation. This migration allows the proteins to be separated by molecular 
weight, whereby smaller proteins migrate a further distance through the polyacrylamide gel in 
comparison to the larger proteins. Samples were loaded onto the gel (25 µl/well) and 
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electrophoresed (150 V, 1 h). Thereafter, protein bands present in the gel were transferred to a 
nitrocellulose membrane. The transfer method involves stacking the electrophoresed 
polyacrylamide gel, nitrocellulose membrane and fibre pads in a cassette, submerged in tank 
buffer and an external electric current is applied (400 mA, 1 h) (Figure 2.11). The electric current 
allows the transfer of the protein bands from the gel to the membrane. 
 
Figure 2.11: Transfer of proteins from the SDS gel to the nitrocellulose membrane (Mahmood 
and Yang, 2012). 
 
2.14.3 Immunodetection  
Immunodetection is a multistep process. The nitrocellulose membrane containing the transferred 
protein bands were incubated with a protein solution which covers the entire surface of the 
membrane to prevent non-specific binding of proteins. Membranes were blocked with 5% BSA 
in Tris buffer saline (20 mM Tris-HCl (pH 7.4), 500 mM NaCl and 0.01% Tween 20 (TBST)) for 
2 h. An indirect method of immunodetection was implemented whereby two different antibodies 
were used in succession, as depicted in Figure 2.12. The membranes were probed with primary 
antibodies: NF-kB p65 (ab3033, Cell Signalling), phospho-STAT3 (ab9145, Cell Signalling), 
total-STAT3 (ab4904, Cell Signalling) and PARP-1 (ab110915, Cell Signalling), diluted to 
1:1000 in 5% BSA. The membranes were then incubated for 2 h on a shaker at RT followed by 
overnight incubation at 4°C. After incubation, membranes were equilibrated to RT, washed 5 
times (10 ml TTBS, 10 min) and incubated with horse radish peroxidase (HRP)-conjugated 




Figure 2.12: Overview of indirect immunodetection involving antigen-antibody interactions 
(Prepared by author).  
 
Membranes were washed 5 times (TTBS, 10 min). A Clarity Western luminal/enhancer solution 
and peroxide substrate solution (catalog no. 1705061, Bio-Rad) was added onto each electro-
blotted nitrocellulose membrane to form the antigen-antibody complex. The generated signal was 
detected using the Chemidoc™ Imaging System (Bio-Rad) and protein expression was analysed 
with Image Lab™ Software (Bio-Rad). The membranes were then quenched with 5% H2O2, 
rinsed thrice (10 min,  TTBS), blocked in 5% BSA (2 h; RT) and probed with β-actin (ab8226) 
(Sigma, St Louis, Missouri, USA)  in a 1:5 000 dilution with 5% BSA (30 min)  for protein 
normalisation and loading control. The data was expressed as fold change (FC). 
 
2.15 Statistical Analysis 
Data was expressed as mean optical density with standard deviations for the MTT assay and IC50 
was determined using the dose-response inhibition equation (Log inhibition versus variable 
slope). For the data obtained from subsequent assays, an unpaired t-test with Welch’s correction 
was performed. The data was represented as means ± standard deviations. A p value of 0.05 was 
considered to be statistically significant. These statistical tests are available on GraphPad prism 








3.1.1 MTT assay 
MOE toxicity in HepG2 cells was determined using the MTT assay. A dose-response was 
determined using MOE concentrations in the range 0 to 4 000 μg/ml for 72h (95% Cl= 30.52 to 
40.77) (Figure 3.1). Analysis of the curve showed that 754.0 μg/ml MOE caused 50% cytotoxicity 
in HepG2 cells. This IC50 concentration was used in all subsequent assays (Appendix A). 
 
Figure 3.1: Cell viability of HepG2 cells treated with MOE for 72h. Data is represented as viable 
cell percentage relative to the untreated control. A dose-dependent decline was observed in HepG2 
cell viability after MOE treatment. 
 
3.1.2 ATP Assay:  
Cellular ATP levels were quantified using the Cell Titre-Glo® assay. MOE significantly reduced 
ATP levels 1.46-fold (3 507 000 ± 201 700 RLU) compared to the control (4 982 000 ± 96 820 




Figure 3.2: Intracellular ATP levels were significantly depleted in MOE treated cells after 72 h 
(* p < 0.0441). RLU: relative light units. 
 
3.1.3 Cytochrome P450 3A4 activity 
P450-Glo™ assay was used to determine CYP3A4 catalytic activity. A significant 1.38-fold 
decrease was seen in CYP3A4 activity in MOE treated cells (1 020 ± 1.155 RLU) compared to 
the control cells (1 411 ± 46.19 RLU, p < 0.0004). Dexamethasone was used as a positive control 
(6730 ± 875.9 RLU, p < 0.0012) (Figure 3.3). 
 
Figure 3.3: MOE decreased CYP3A4 activity in HepG2 cells in comparison to the control 




3.2 Oxidative stress 
3.2.1 TBARS assay 
Lipid peroxidation induced by ROS was assessed by quantification of MDA levels. The MDA 
levels were elevated in the MOE treated cells (0.3482 ± 0.013 μM, 1.23-fold) compared to the 
untreated cells (0.2821 ± 0.006 μM, p < 0.05) (Figure 3.4). 
 
Figure 3.4: Extracellular MDA levels in Control and MOE treatment (* p < 0.05). 
 
3.2.2 Nitrates and nitrites assay 
The concentration of nitrates and nitrites was determined by extrapolation from a standard curve 
(Appendix C). Figure 3.5 shows a 1.17-fold increase (p < 0.2905) in nitrates and nitrites 





Figure 3.5: The nitrates and nitrites concentration in HepG2 cells following treatment with 




3.2.3 LDH assay: 
Extracellular levels of LDH were quantified using a colorimetric assay. Results showed a 1.17 
fold increase in LDH levels in the supernatant of the MOE treated cells (1.254 ± 0.008 OD, p < 
0.0035) compared to that of the control supernatant (1.068 ± 0.017 OD) (Figure 3.6). Results are 
presented as mean optical density (OD). 
 
Figure 3.6: Extracellular LDH levels in MOE treated supernatant versus Control (** p < 
0.0035). 
 
3.2.4 SCGE Assay 
The comet assay was performed to assess DNA fragmentation following treatment with MOE. 
Longer comet tail length is associated with higher DNA fragmentation. Figure 3.7 shows comet 
tails were significantly longer in the cells treated with MOE compared to the control cells 















Figure 3.7: A.  Comet tails of HepG2 cells (a) prior to MOE exposure and (b) after 72 h MOE 
treatment (p < 0.0001). B. Comet tail length was significantly higher in MOE treated cells 
compared to control (*** p < 0.0001). 
 
3.3 Inflammation 
3.3.1 Western blot 
Western blotting was used to determine the effects of MOE on protein expression of NF-kB p65, 
phospho-STAT3 (p-STAT3) and PARP-1. MOE induced significant 1.31-fold increase in 
expression of NF-kB p65 (1.317 ± 0.05767 vs control: 1.004 ± 0.005474 RFC, p < 0.0112) and 
2.78-fold increase in p-STAT3 expression (3.786 ± 0.8184 vs control: 1.004 ± 0,005508 RFC, p 
< 0.0277). MOE induced the cleavage of PARP-1 to yield an 89 kDa and 24 kDA fragment 
(Figure 3.8). Analysis of the fragments showed a 1.17-fold decrease of 89 kDA fragment (1.004 
± 0.005474 vs control: 1.201 ± 0.05632 RFC, p < 0.0263) and a 1.11 fold increase in expression 
of the 24 kDA fragment (0.1.115 ± 0.008967 vs control: 1.001 ± 0.0006364 RFC, p < 0.0354). 
(Appendix F). 
 
Figure 3.8: Western Blot images and graphs of NF-kB, p-STAT3 and cleaved PARP. Protein 
expression analysis showed a significant increase in A. NF-kB (* p < 0.05) and B. p-STAT3 (* p 
< 0.05) in MOE treatment. MOE treated cells depicted a significant decrease in C. 89 kDa 








The effects of MOE on HepG2 cells cytokine production was assessed using ELISA. There was a 
significant increase in IL-6 (1.2-fold) and a non-significant increase in TNF- (1.03-fold), IL-10 
(1.03-fold) and IL-1β (1.05-fold) cytokine concentration in MOE treated cells compared to 
untreated, controls cells (Table 3.1). (Appendix D). 
Table 3.1: Cytokine concentrations in MOE treated cells. 
 
Cytokine Mean ± SD (pg/ml) p value 
 Control MOE  
IL-6 145.5 ± 8.378 174.7 ± 2.734 0.0292* 
TNF-a 52.43 ± 3.024 54.05 ± 1.859 0.4872 
IL-10 294.3 ± 11.81 303.3 ± 2.417 0.3238 
IL-1β 28.43 ± 0.9074 29.73 ± 0.4726 0.1151 
SD: Standard deviation, *: significant 
 
3.4 Cell death 
3.4.1 Caspase activation 
Intracellular activity of caspases 8, 9 and 3/7 was measured. Following MOE treatment, there was 
a 1.47-fold decrease in caspase 8 and a 1.34-fold decrease in caspase 9 activities (Table 3.2). A 
significant 2.83-fold increase of caspase 3/7 activity was observed in MOE treated compared to 
the control cells. (Appendix E). 
Table 3.2: Intracellular caspase 8, 9 and 3/7 activities in MOE treated cells. 




Caspase 8 61 450 ± 1 784 41 710 ± 2 732 0.0741 
Caspase 9 685 200 ± 18 960 510 000 ± 10 730 0.0558 
Caspase 3/7 63 350 ± 12 000 179 200 ± 1 535 * 0.0469 
SD: Standard deviation, *: significant 
 
3.4.2 Hoechst assay 
Using the Hoechst 33342, the detection of morphological hallmarks of apoptosis were observed 
including cell shrinkage, nuclear condensation, apoptotic bodies and apoptotic cells (Figure 3.9: 
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B and C). This was compared to the control cells which showed cell division at various stages of 
the cell cycle (Figure 3.9: A). Cell density was reduced in the MOE treatment compared to the 
control. 
 
Figure 3.9: Hoechst 33342 stained HepG2 cells displaying cell cycle morphology. A. HepG2 
control cells showing (a) metaphase, (b) anaphase, (c) early telophase and (d) interphase. B and 
C. MOE induced (e) chromatin hypercondensation, (f) cell shrinkage, (g) formation of apoptotic 







Moringa oleifera (MO) is a deciduous plant widely cultivated throughout tropical and sub-
tropical countries of the world including Africa and Asia (Berkovich et al., 2013). The plant has 
gained popularity due to its various medicinal properties attained by the bio-active phytochemical 
composition of its leaves. It is frequently used in the traditional treatment of a variety of illnesses 
such as anaemia, hypertension, hypercholesterolemia, diabetes mellitus type 2 and cancer (Koh 
et al., 2013; Leone et al., 2015). The biochemical effects of MOE on human HCC have not yet 
been fully elucidated. It was hypothesised that MOE induces cytotoxic effects on HepG2 liver 
cancer cells upon chronic exposure (72 h).  
The mitochondrion is a double-membrane organelle that plays a central role in cellular energy 
metabolism and is the major source of ROS production through oxidative phosphorylation 
(Gottlieb, 2001; Baynes and Dominiczak, 2007; Martinou and Youle, 2011). Normal cellular 
metabolism generates moderate levels of ROS which serves as an important stimulator of several 
signalling pathways involved in cell communication, immune responses and inflammation 
(Reuter et al., 2010). ROS is directly generated as a by-product of the ETC within mitochondria 
of cells and is modulated by oxidative phosphorylation which involves the flow of electrons 
through the ETC complexes (Repetto et al., 2012). Excessive production of ROS is implicated in 
a wide variety of diseases including chronic inflammation and subsequent cancer development 
(Poyton et al., 2009; Reuter et al., 2010). The chronic persistence of oxidative stress caused by 
the overproduction of ROS, predominantly O2.- and H2O2, has the capacity to damage cellular 
components and structure (Repetto et al., 2012; Tiloke et al., 2016). Cellular targets of ROS 
include DNA, lipids and proteins (Repetto et al., 2012; Tiloke et al., 2016).  
The mitochondrion is not only the major source of ROS production, but it is also a highly 
susceptible target for ROS molecules and their damaging effects (Orrenius, 2007). The MTT 
assay indicated a dose dependent decrease in HepG2 cell viability (Figure 3.1), thus demonstrating 
the cytotoxic potential of MOE. The decrease in cell viability is caused by reduced mitochondrial 
MTT conversion due to decreased enzymatic activity of mitochondrial succinate dehydrogenase 
and/or decreased availability of reducing equivalents such as co-enzyme NADH, (Stockert et al., 
2012). MOE also decreased intracellular ATP generation (Figure 3.2).  Highly reactive ROS 
molecule O2.- can  directly oxidise and inactivate iron-sulphur proteins such as NADH 
dehydrogenase and ATP synthase causing the loss of mitochondrial respiration and ATP 
generation ultimately resulting in mitochondrial dysfunction and decreased intracellular ATP 
concentrations (Orrenius, 2007). Additionally, glucose uptake is facilitated by carbohydrate 
digestive enzymes, α-glucosidase and α-amylase. Tannins, flavonoids and phenolic compounds 
present within the extract are responsible for inhibition of α-glucosidase and α-amylase enzyme 
activity thereby preventing glucose uptake and absorption. (Adisakwattana and Chanathong, 
2011). This would result in decreased TCA cycle and glycolysis which is responsible for the 
production of reducing equivalents NADH and FADH2. These co-enzymes supply electrons to 
the ETC in the mitochondria and facilitate ATP production via oxidative phosphorylation. Thus 
a decrease in the concentration of reducing equivalents would indicate decreased number of 
electrons entering the ETC and consequentially, ATP production would also decrease (Adeeyo et 
al., 2013).   
A major detrimental effect of ROS-induced oxidative stress is the induction of lipid peroxidation 
(Repetto et al., 2012). Numerous end-products are produced following lipid peroxidation, such 
as aldehydes, more specifically MDA (Repetto et al., 2012).  The results from the study indicated 
that MOE increased MDA concentration (Figure 3.4) suggesting that MOE is a potent inducer of 
oxidative stress within HepG2 cells, resulting in lipid peroxidation. This result is in agreement 
with a study conducted by Tiloke et al (2013) implicating MOE in the induction of ROS within 
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A549 lung cancer cells (Tiloke et al., 2013). Although this study did not analyse each plant 
phytochemical compound within MO, a previous study conducted by Singh et al. (2009) 
identified the presence of quercetin and kaempferol, two flavonoids existing in substantial 
quantities within the crude aqueous extract (Singh et al., 2009). This finding was further verified 
by Sreelantha et al (2009, 2011) and it was suggested quercetin and kaempferol may be inducers 
of elevated ROS production (Sreelatha and Padma, 2009; Sreelatha et al., 2011). 
Generally, cell membranes have a high content of PUFAs and is the main target of ROS-induced 
oxidative destruction, particularly due to its methylene group (=RH-). The physiological role of 
PUFAs include regulation of gene expression, cell signalling, selectively permeable barrier, a 
support system for membrane structure, flexibility and fluidity and providing of energy. Therefore 
lipid peroxidation induced by excessive ROS production is responsible for oxidative damage and 
reduced functionality of cell membranes (Repetto et al., 2012).  MOE significantly increased 
extracellular LDH levels (Figure 3.6), thereby strongly indicating HepG2 cell membrane damage.  
This study also investigated the production of RNS in response to MOE exposure. There was a 
non-significant increase in nitrates and nitrites levels (Figure 3.5) suggesting that the 
concentration of nitrates and nitrites was not affected by MOE. Since the nitrates and nitrite 
concentration was not depleted, and was evidently present, it still may contribute to oxidative 
stress to a small extent by providing substrates for RNS generation.  MOE contains niacin as well 
as vitamin D3, vitamin C and magnesium, all of which stimulates NO production (Houston, 2013; 
Gopi et al., 2016).  In states of elevated ROS levels, NO combines with O2- to form OON- which 
induces lipid peroxidation (Oboh et al., 2015). Therefore, both ROS and RNS contribute to 
oxidative stress-induced lipid peroxidation (Dedon and Tannenbaum, 2004).  
In the liver,  constitutively activated NF-kB promotes cellular regeneration and inhibits apoptosis 
thus enabling cancer progression (Barkett and Gilmore, 1999). It is well-known that NF-kB 
expression is regulated by ROS (Wang et al., 2015). This study showed MOE increased the 
expression of NF-kB in HepG2 cancer cells (Figure 3.8). Previously it was observed that MOE 
increased ROS production, one source of ROS predominantly responsible for the activation of 
NF-kB is H2O2. It can directly exert its effect or through its transformation into OH● whilst in the 
presence of Fe2+ in the Fenton reaction (Gloire et al., 2006). These findings suggest MOE induced 
ROS-mediated pro-apoptotic NF-kB transcriptional activity in HepG2 cells (Gloire et al., 2006).  
NF-kB transcriptional activity leads to the activation of various pro- and anti-inflammatory genes 
including TNF-, IL-1β, IL-10 and IL-6 (Niemand et al., 2003). TNF- initiates and amplifies 
the inflammatory response (Hammam et al., 2013), IL-1β is a major mediator of inflammation 
(Dinarello, 2009) and IL-10 is a potent anti-inflammatory cytokine capable of supressing pro-
inflammatory cytokine release (Niemand et al., 2003). MOE induced non-significant increases in 
the concentrations of TNF-, IL-1β, IL-10 (Table 3.1).  
TNF- is also associated with activation of the extrinsic apoptotic pathway (Hammam et al., 
2013). In this pathway, caspase 8 is the main initiator caspase, functional in the cleavage and 
activation of  caspase 3/7 (Elmore, 2007). In this study, HepG2 cells exposed to MOE expressed 
a non-significant increase in TNF- concentration (Table 3.1) and a non-significant decrease in 
caspase 8 activity (Table 3.2) and a significant increase in caspase 3/7 activity (Table 3.2). A 
second apoptotic pathway is the mitochondrial intrinsic pathway where cleavage and activation 
of caspase 3/7 is carried out by initiator caspase 9 (Elmore, 2007). Once again, it was observed 
that MOE exposed cells expressed a non-significant decrease in caspase 9 activity (Table 3.2). 
Collectively, these findings indicate that both the extrinsic and intrinsic apoptotic pathways were 
not activated by MOE and its likely caspase 3/7 activation occurred via another pathway. 
Pleiotropic cytokine, IL-6 promotes cell survival and is the primary activator of STAT3 through 
IL-6 induced transcriptional phosphorylation of tyrosine 705 residue of STAT3 (Yu et al., 2009; 
Wang et al., 2011). MOE induced a significant increase in both IL-6 (Table 3.1) and protein 
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expression of p-STAT3 (Figure 3.8). Once STAT3 is activated, it induces further expression and 
subsequent production of IL-6 thereby creating a positive feedback mechanism causing excessive 
STAT3 activation and IL-6 production. Over activation of STAT3 induces apoptosis in cancer 
cells (Silva et al., 2015; Rozovski et al., 2016). Under normal conditions, IL-6 and activated 
STAT3 serves to inhibit apoptosis, promote malignant cell transformation and inflammation 
through the inhibition of pro-inflammatory proteins but excessive activation of STAT3 results in 
binding of activated STAT3 to STAT3-specific binding sites within caspase 3/7-gene promoter 
region causing increased transcription of procaspase 3/7. The high levels of activated STAT3 then 
binds with low affinity to STAT3-specific binding sites within the promoter region of procaspase 
3/7 to initiate caspase activity (Silva et al., 2015; Rozovski et al., 2016). 
In advanced cancers such as HCC, significantly reduced activity of CYP3A4 is often experienced. 
MOE induced a significant decrease in CYP3A4 activity (Figure 3.3). IL-6 cytokine release 
represses the hepatic IL-6 gene transcription resulting in reduced CYP3A4 mRNA, protein and 
activity (Morgan et al., 2008). This suggests that HepG2 cancer cells are highly susceptible and 
sensitive to the cytotoxicity of MOE due to their reduced capacity to metabolise MOE. 
Caspase-dependent apoptosis involves PARP-1 cleavage by executioner caspase 3/7 at the 
aspartate-glutamine-valine-aspartate (DEVD) site located in the nuclear localisation signal (NLS) 
region of PARP-1. This cleavage generates two fragments of 89 kDa and 24 kDa. The 89 kDa 
fragment contains the auto-modification and catalytic domain whereas the 24 kDa fragment 
possess the DNA-binding domain and the double zinc fingers. Cleavage of PARP-1 is known to 
prevent repair of ds/ssDNA breaks and cell survival. MOE caused PARP-1 cleavage with a 
significant increase in the 24 kDa fragment (Figure 3.8). This further indicates MOE as an 
apoptotic inducer in HepG2 cells. The 24 kDa fragment binds irreversibly to DNA strand breaks 
thus preventing DNA repair, eventually resulting in cell death. DNA damage induced by MOE 
was further validated by the presence of increased strand breaks represented by increased comet 
tail lengths (Figure 3.7). In combination, increased DNA strand breaks and PARP-1 cleavage 
signifies genotoxic potential of MOE resulting in cellular dysfunction and apoptosis.  
Late stages of apoptosis can be identified by characteristic changes of the cell and nuclear 
morphology but overall the most prominent indicator of apoptosis is the formation of apoptotic 
bodies. Figure 3.9 (B and C) shows that MOE induced chromatin hypercondensation and 
shrinkage of cells, formation of apoptotic bodies were also seen in greater quantity in MOE treated 
cells compared to the untreated control cells (Figure 3.9 (A)). Apoptotic cells were also present 




Figure 4.1: Schematic overview of the biochemical effects of MOE in human HepG2 cells 







MO is a highly nutritional plant, consumed worldwide. It possesses many medicinal properties 
and is associated with pharmacological activities that may aid in the development of new 
anticancer treatment modalities. However, the mechanism by which MOE causes cytotoxicity in 
human HCC has not yet been investigated and established. In this study, the cytotoxic effects of 
MOE on the HepG2 cell line following chronic exposure (72 h) was determined (Figure 4.1).  
The results from the study showed that MOE induced ROS-mediated lipid peroxidation causing 
reduced mitochondrial viability, ATP depletion, and membrane and DNA damage. MOE did not 
act via the typical NF-kB inflammatory pathway but instead induced the pro-apoptotic 
transcriptional activity of NF-kB through elevation of ROS levels thus triggering the IL-6/STAT3 
pathway. The positive feedback loop that occurs between IL-6 and STAT3 results in STAT3 
binding to STAT3-specific binding domains located on procaspase 3/7 to initiate caspase activity. 
Activated caspase 3/7 subsequently cleaves and inactivates PARP-1 leading to the inhibition of 
DNA repair, ultimately resulting in cell death. Taken together, MOE is an anti-proliferative, 
cytotoxic and genotoxic agent in human HepG2 cancer cells. Understanding the underlying 
biochemical mechanism of toxicity of MOE on HepG2 cells may aid in the development of new 
promising therapeutic treatments for HCC.  
Phytochemical analysis of the bioactive compounds present in MOE is further recommended for 
future studies.  It would be of interest to identify the compounds responsible for the cytotoxicity 
of MOE seen in the liver cell line. Further studies are also required to determine the effect of 
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HepG2 cells were treated with a range of MOE concentration (0 – 4 000 µg/ml) over a 72 h period. 
A dose-dependent decrease in HepG2 cell viability was observed and an IC50 of 754.0 µg/ml was 
determined (Appendix Table 1). 
Table 1: The determination of the IC50 using the cell viability (MTT) assay. 
MOE Concentration (μg/ml) Average Absorbance % Viability Log[MOE] 
0 1.14533 100  
250 0.93600 82 2.39794 
500 0.85867 75 2.69897 
1 000 0.53333 47 3.00000 
1 500 0.49633 43 3.17609 
2 000 0.41433 36 3.30103 
3 000 0.41467 36 3.47712 


















Glucose 1 000.0 
















Choline Chloride 1.0 










Table 1: The determination of the nitrates and nitrites standard reference curve.  
Nitrite Standard Concentrations (µM) OD1 OD2 OD3 Average OD 
0 0.02 0.018 0.018 0.018667 
12.5 0.074 0.068 0.071 0.071 
25 0.153 0.14 0.137 0.143333 
50 0.263 0.239 0.234 0.245333 
100 0.484 0.434 0.455 0.457667 
200 0.938 0.907 0.918 0.921 
 
 
Figure 1: Nitrates and nitrites Standard reference curve used to determine nitrates and nitrites 





























Table 1: Determination of the IL-6 standard reference curve. 
Standard Concentration (pg/ml) Average OD Average OD - Average Blank OD 
0 0.349 -1.003 
4.7 0.3825 -0.9695 
9.4 0.4165 -0.9355 
18.8 0.5095 -0.8425 
37.5 0.5755 -0.7765 
75 0.8325 -0.5195 
150 1.1975 -0.1545 
300 2.0345 0.6825 
Blank 1.003  
 
 
Figure 1: Standard reference curve using a range of known IL-6 concentrations for determination 




























Table 2: Determination of the TNF-  standard reference curve. 
Standard Concentration (pg/ml) Average OD Average OD - Average Blank OD 
0 0.147 -0.2605 
7.8 0.146 -0.2615 
15.6 0.168 -0.2395 
31.3 0.232 -0.1755 
62.5 0.3715 -0.036 
125 0.585 0.1775 
250 1.0505 0.643 





Figure 2: Standard reference curve using a range of known TNF- concentrations for 
determination of sample cytokine concentrations using ELISA. 
 
  





























Table 3: Determination of the IL-10 standard reference curve. 
Standard Concentration (pg/ml) Average OD Average OD - Average Blank OD 
0 0.258 -0.6825 
7.8 0.177 -0.7635 
15.6 0.2965 -0.644 
31.3 0.223 -0.7175 
62.5 0.3455 -0.595 
125 0.4745 -0.466 
250 0.774 -0.1665 
500 1.012 0.0715 





Figure 3: Standard reference curve using a range of known IL-10 concentrations for 






























Table 4: Determination of the IL-1β standard reference curve. 
Standard Concentration (pg/ml) Average OD Average OD - Average Blank OD 
0 0.106 -0.2605 
3.9 0.1115 -0.255 
7.8 0.161 -0.2055 
15.6 0.218 -0.1485 
31.3 0.351 -0.0155 
62.5 0.594 0.2275 
125 1.0335 0.667 
250 1.8205 1.454 
Blank 0.2605  
 
 
Figure 4: Standard reference curve using a range of known IL-1β concentrations for 





























Figure 5:  A. IL-6 concentration was significantly higher in cells exposed to MOE compared to 
control cells (p < 0.05). There was a non-significant increase in B. TNF-, C. IL-10 and D. IL-














Figure 1: The activity of caspase 8 was non-significantly decreased in cells exposed to MOE 
compared to control cells (p > 0.05). 
 
 
Figure 2: The activity of caspase 9 was non-significantly decreased in cells exposed to MOE 





Figure 3: Caspase 3/7 activity was significantly higher in cells exposed to MOE compared to 






Table 1: Protein Quantification and Standardisation using Bovine Serum Albumin (BSA). 
Protein Standard (mg/ml) OD1 OD2 OD3 Average OD 
0 0 0.114 0.112 0.075333333 
0.2 0.498 0.502 0.591 0.530333333 
0.4 0.8 0.831 0.72 0.783666667 
0.6 1.071 1.055 1.135 1.087 
0.8 1.471 1.396 1.347 1.404666667 
1 1.725 1.549 1.67 1.648 
 
 
Figure 1: Standard calibration curve using a range of known bovine serum albumin 




Table 2: Standardisation of protein using the standard calibration curve for Sodium dodecyl 
































Average OD Protein (mg/ml) C2 (mg/ml) V2 (µl) V1 (µl) 
Control 3.8535 2.4 1.5 150 93.75 
MOE 3.6945 2.3 1.5 150 97.83 
